PROSPECTUS
SUPPLEMENT |
Filed
Pursuant to Rule 424(b)(5) |
(To
Prospectus dated December 1, 2021) |
Registration
No. 333-261452 |
Zion
Oil & Gas, Inc.
Up
to $100,000,000
Dividend
Reinvestment and Common Stock Purchase Plan
This
prospectus relates to shares of common stock and other securities
that we may offer and sell from time to time according to the terms
of the Dividend Reinvestment and Stock Purchase Plan (the “Plan”)
of Zion Oil & Gas, Inc. Participants should retain this
prospectus for future reference.
The
Plan provides participants with a convenient and economical means
of purchasing shares of our common stock by reinvesting cash
dividends paid on our common stock, par value $0.01 (the “Common
Stock”), if and when paid in the future, and by making additional
optional cash purchases. In addition, new investors may make their
initial investment in our common stock under the Plan. Furthermore,
the Plan includes a feature whereby new investors and existing
stockholders can also purchase, directly from Zion, units (each a
“Unit” and collectively the “Units”) of Zion securities, with each
Unit consisting of (i) a share or shares of our Common Stock and
(ii) one or more warrants to purchase an additional share or shares
of our Common Stock at a fixed exercise price (each “Warrant” and
collectively the “Warrants”).
All
securities offered under the Plan will be purchased directly from
Zion. All proceeds from the sales of shares of Common Stock and
Units under the Plan, as well as any exercise of warrants, will be
received by us and applied to our general corporate
purposes.
To
date, we have not paid dividends on shares of our Common Stock or
any other class of capital stock and no assurance can be given as
to when, if ever, we will be able to pay dividends on our Common
Stock. The payment of dividends on our Common Stock is at the
discretion of our Board of Directors. There is no guarantee that we
will pay dividends in the future.
Our
common stock is quoted on the OTCQX under the symbol “ZNOG”. The
Warrants to be issued pursuant to this Plan may be separately
transferable following their issuance through their expiration
date. The Warrant “ZNOGW” is listed on the OTCQX. The Units are
non-transferable.
Investing
in the securities offered by this prospectus is risky. You should
read this prospectus carefully before you invest. You should
carefully consider the “Risk Factors” section beginning on
page S-27 before deciding whether to invest.
The
securities are not being offered in any jurisdiction where the
offer is not permitted under applicable local laws.
Neither
the U.S. Securities and Exchange Commission (SEC) nor any state
securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or
complete. Any representation to the contrary is a criminal
offense.
The
date of this Prospectus Supplement is December 15,
2021.
TABLE
OF CONTENTS
ABOUT THIS PROSPECTUS
SUPPLEMENT
This
document is in two parts. The first part is this prospectus
supplement, which describes the specific terms of Plan and the
securities offered under the Plan. The second part is the
accompanying prospectus, which gives more general information, some
of which may not apply to this offering under the Plan. To the
extent there is a conflict between the information contained in
this prospectus supplement and the information contained in the
accompanying prospectus, you should rely on the information in this
prospectus supplement.
You
should rely only on the information contained or incorporated by
reference in this prospectus supplement, the accompanying
prospectus, and any free writing prospectus that we authorize to be
distributed to you. We have not authorized anyone to provide you
with different or inconsistent information. If anyone provides you
with different or inconsistent information, you should not rely on
it. We are not making an offer to sell these securities in any
jurisdiction where the offer or sale is not permitted. You should
assume that the information appearing in this prospectus
supplement, the accompanying prospectus, the documents incorporated
by reference into this prospectus supplement and the accompanying
prospectus, and any free writing prospectus is accurate only as of
the date of those respective documents. Our business, financial
condition, results of operations, and prospects may have changed
since such dates.
Unless
otherwise indicated, all references to “Zion Oil & Gas”,
“Company”, “our”, “we”, “us”, and similar terms refer to Zion Oil
& Gas, Inc., a Delaware corporation.
PROSPECTUS SUPPLEMENT
SUMMARY
The
following summary highlights selected information contained
elsewhere or incorporated by reference in this prospectus
supplement and the accompanying prospectus. This summary does not
contain all the information that you should consider before
investing in our securities. You should carefully read this entire
prospectus supplement, the accompanying prospectus and any free
writing prospectus that we authorize to be distributed to you,
including the “Risk Factors” section beginning on page S-27 of this
prospectus supplement and, the financial statements and related
notes and other information included or incorporated by reference
in this prospectus supplement and the accompanying prospectus,
before making an investment decision.
Zion
Oil & Gas, Inc.
Zion
Oil and Gas, Inc., a Delaware corporation, is an oil and gas
exploration company with a history of 19 years of oil and gas
exploration in Israel. We were incorporated in Florida on April 6,
2000 and reincorporated in Delaware on July 9, 2003.
We completed our initial public offering in January 2007. Our
common stock, par value $0.01 per share (the “Common Stock”)
currently trades on the OTCQX under the symbol “ZNOG” and our
Common Stock warrant under the symbol “ZNOGW.”
The
Company currently holds one active petroleum exploration license
onshore Israel, the New Megiddo License 428 (“NML 428”), comprising
approximately 99,000 acres. The NML 428 was awarded on
December 3, 2020 for a six-month term with the possibility of an
additional six-month extension. On April 29, 2021, Zion submitted a
request to the Ministry of Energy for a six-month extension to
December 2, 2021. On May 30, 2021, the Ministry of Energy approved
our request for extension to December 2, 2021. On November 29,
2021, the Ministry of Energy in Israel granted Zion Oil & Gas
an extension of the “New Megiddo”/428 License until August 1, 2022
for the purpose of completing the activities regarding its MJ-02
drilling and testing. The ML 428 lies onshore, south and west of
the Sea of Galilee and we continue our exploration focus here, as
it appears to possess the key geologic ingredients of an active
petroleum system with significant exploration potential.
The
Megiddo Jezreel #1 (“MJ #1”) exploratory well was spud on June 5,
2017 and drilled to a total depth (“TD”) of 5,060 meters
(approximately 16,600 feet). Thereafter, the Company successfully
cased and cemented the well while awaiting the approval of the
testing protocol. The Ministry of Energy approved the well testing
protocol on April 29, 2018.
During
the fourth quarter of 2018, the Company testing protocol was
concluded at the MJ #1 well. The test results confirmed that the MJ
#1 well did not contain hydrocarbons in commercial quantities in
the zones tested. As a result, in the year ended December 31, 2018,
the Company recorded a non-cash impairment charge to its unproved
oil and gas properties of $30,906,000. During the six months ended
June 30, 2021, and 2020, respectively, the Company did not record
any post-impairment charges.
While
the well was not commercially viable, Zion learned a great deal
from the drilling and testing of this well. We believe that the
drilling and testing of this well carried out the testing
objectives, which would support further evaluation and potential
further exploration efforts within our License area. Zion believed
it was prudent and consistent with good industry practice to try to
answer some of these questions with a focused 3-D seismic imaging
shoot of approximately 72 square kilometers surrounding the MJ#1
well. Zion completed all of the acquisition, processing and
interpretation of the 3-D data and incorporated its expanded
knowledge base into the drilling of our current MJ-02 exploratory
well.
At
present, we have no revenues or operating income. Our ability to
generate future revenues and operating cash flow will depend on the
successful exploration and exploitation of our current and any
future petroleum rights or the acquisition of oil and/or gas
producing properties, and the volume and timing of such production.
In addition, even if we are successful in producing oil and gas in
commercial quantities, our results will depend upon commodity
prices for oil and gas, as well as operating expenses including
taxes and royalties.
Our
executive offices are located at 12655 North Central Expressway,
Suite 1000, Dallas, Texas 75243, and our telephone number is (214)
221-4610. Our branch office’s address in Israel is 9 Halamish
Street, North Industrial Park, Caesarea 3088900, and the telephone
number is +972-4-623-8500. Our website address is:
www.zionoil.com.
Exploration
and Operation Efforts
Megiddo-Jezreel
Petroleum License
The
Company held an active petroleum exploration license onshore
Israel, the Megiddo-Jezreel License, comprising approximately
99,000 acres. The Megiddo Jezreel #1 (“MJ #1”) exploratory
well was spud on June 5, 2017 and drilled to a total depth (“TD”)
of 5,060 meters (approximately 16,600 feet). Thereafter, the
Company successfully cased and cemented the well while awaiting the
approval of the testing protocol. The Ministry of Energy approved
the well testing protocol on April 29, 2018.
During
the fourth quarter of 2018, the Company’s testing protocol was
concluded at the MJ #1 well. The test results confirmed that the MJ
#1 well did not contain hydrocarbons in commercial quantities in
the zones tested. The MJ#1 well provided Zion with
information Zion believes is important for potential future
exploration efforts within its license area. As with many frontier
wildcat wells, the MJ#1 also left several questions
unanswered.
While
not meant to be an exhaustive list, a summary of what Zion believes
to be key information learned in the MJ#1 well is as
follows:
|
1. |
The
MJ#1 encountered much higher subsurface temperatures at a depth
shallower than expected before drilling the well. In our opinion,
this is significant because reaching a minimum temperature
threshold is necessary for the generation of hydrocarbons from an
organic-rich source rock. |
|
|
|
|
2. |
The
known organic rich (potentially hydrocarbon bearing) Senonian age
source rocks that are typically present in this part of Israel were
not encountered as expected. Zion expected these source rocks to be
encountered at approximately 1,000 meters in the MJ#1
well. |
|
3. |
MJ#1
had natural fractures, permeability (the ability of fluid to move
through the rock) and porosity (pore space in rock) that allowed
the sustained flow of formation fluid in the shallower Jurassic and
lower Cretaceous age formations between approximately 1,200 and
1,800 meters. While no hydrocarbons were encountered, Zion believes
this fact is nonetheless significant because it provides important
information about possible reservoir pressures and the ability of
fluids to move within the formation and to the surface. |
|
|
|
|
4. |
MJ#1
encountered oil in the Triassic Mohilla formation, which Zion
believes suggests an active deep petroleum system is in Zion’s
license area. There was no natural permeability or porosity in the
Triassic Mohilla formation to allow formation fluid to reach the
surface naturally during testing, and thus the MJ#1 was not
producible or commercial. |
|
|
|
|
5. |
The
depths and thickness of the formations we encountered varied
greatly from pre-drill estimates. This required the MJ#1 to be
drilled to a much greater depth than previously expected. Zion has
tied these revised formation depths to seismic data which will
allow for more accurate interpretation and mapping in the
future. |
A
summary of what Zion believes to be some key questions left to be
answered are:
|
1. |
Is
the missing shallow Senonian age source rock a result of regional
erosion, or is it missing because of a fault that cut the well-bore
and could be reasonably expected to be encountered in the vicinity
of the MJ#1 drill site? Zion believes this is an important question
to answer because if the Senonian source rocks do exist in this
area, the high temperatures encountered are sufficient to mature
these source rocks and generate oil. |
|
|
|
|
2. |
Do
the unusually high shallow subsurface temperatures extend
regionally beyond the MJ#1 well, which could allow for the
generation of hydrocarbons in the Senonian age source rock within
our license area? |
|
|
|
|
3. |
As a
consequence of seismic remapping, where does the MJ#1 well lie
relative to the potential traps at the Jurassic and Triassic
levels, and was the well location too low on the structures and
deeper than the potential hydrocarbons within those
traps?
As a
result of these unanswered questions and with the information
gained drilling the MJ#1 well, Zion believed it was prudent and
consistent with good industry practice to try and answer some of
these questions with a focused 3-D seismic imaging shoot of
approximately 72 square kilometers surrounding the MJ#1 well. Zion
has completed all of the acquisition, processing and interpretation
of the 3-D data and incorporated its expanded knowledge base into
the drilling of our current MJ-02 exploratory well (see further
details below). The Geology team is continuing to work on a larger
interpretation of 3D areas, along with potential exploration
locations located in the western portion of the NML 428 license
area.
|
Map
1. Zion’s Megiddo-Jezreel Petroleum Exploration
License.
As a
result of these unanswered questions and with the information
gained drilling the MJ#1 well, Zion believed it was prudent and
consistent with good industry practice to try and answer some of
these questions with a focused 3-D seismic imaging shoot of
approximately 72 square kilometers surrounding the MJ#1 well. Zion
has completed all of the acquisition, processing and interpretation
of the 3-D data and has incorporated its expanded knowledge base
into the drilling of our current MJ-02 exploratory well (see
further details below). The Megiddo-Jezreel License 401 was awarded
on December 3, 2013 for a three-year primary term through December
2, 2016 with the possibility of additional one-year extensions up
to a maximum of seven years. The Megiddo-Jezreel License 401 lies
onshore, south and west of the Sea of Galilee, and we continue our
exploration focus here as it appears to possess the key geologic
ingredients of an active petroleum system with significant
exploration potential.
Current
Exploration and Operation Efforts
On
March 12, 2020, Zion entered into a Purchase and Sale Agreement
with Central European Drilling kft, a Hungarian corporation, to
purchase an onshore oil and gas drill rig, drilling pipe, related
equipment and spare parts for a purchase price of $5.6 million in
cash, subject to acceptance testing and potential downward
adjustment. We remitted to the Seller $250,000 on February 6, 2020
as earnest money towards the Purchase Price. The Closing
anticipated by the Agreement took place on March 12, 2020 by the
Seller’s execution and delivery of a Bill of Sale to us. On March
13, 2020, the Seller retained the earnest money deposit, and the
Company remitted $4,350,000 to the seller towards the purchase
price, and $1,000,000 (the “Holdback Amount”) was deposited in
escrow with American Stock Transfer and Trust Company LLC. On
January 6, 2021, Zion completed its acceptance testing of the I-35
drilling rig and the Holdback Amount was remitted to Central
European Drilling.
The
Company currently holds one active petroleum exploration license
onshore Israel, the New Megiddo License 428 (“NML 428”), comprising
approximately 99,000 acres. This license effectively replaced
the Megiddo-Jezreel License 401 as it has the same area and
coordinates. The NML 428 was awarded on December 3, 2020 for a
six-month term with the possibility of an additional six-month
extension. On April 29, 2021, Zion submitted a request to the
Ministry of Energy for a six-month extension to December 2, 2021.
On May 30, 2021, the Ministry of Energy approved our request for
extension to December 2, 2021. On November 29, 2021, the Ministry
of Energy in Israel granted Zion Oil & Gas an extension of the
“New Megiddo”/428 License until August 1, 2022 for the purpose of
completing the activities regarding its MJ-02 drilling and testing.
The ML 428 lies onshore, south and west of the Sea of Galilee, and
we continue our exploration focus here as it appears to possess the
key geologic ingredients of an active petroleum system with
significant exploration potential.
The
MJ-02 drilling plan was approved by the Ministry of Energy on July
29, 2020. On January 6, 2021, Zion officially spudded its MJ-02
exploratory well. On November 23, 2021 Zion announced that it
completed the drilling of the MJ-02 well to a total depth of 5,531
meters (~18,141 feet). A full set of detailed and comprehensive
tests including neutron-density, sonic, gamma, and resistivity
logs, paired with well testing, have commenced. Based on these logs
and analysis, additional zones of interest may be identified and
tested.
Plan
Summary
We
are offering new investors and existing stockholders a convenient
method to purchase shares of Common Stock directly from Zion and to
reinvest cash dividends paid on Zion’s Common Stock in the purchase
of additional shares of Common Stock. In addition, the Plan
includes a feature whereby new investors and existing stockholders
can also purchase, directly from Zion, units (each a “Unit” and
collectively the “Units”) of Zion securities, with each Unit
consisting of (i) one or more shares of our Common Stock and (ii)
one or more warrants to purchase one or more additional shares of
our Common Stock at a fixed exercise price (each a “Warrant” and
collectively the “Warrants”), all as described
below.
The
Plan is administered by the American Stock Transfer & Trust
Company, LLC, a New York limited liability trust company (“AST”),
located at 6201 15th Avenue, Brooklyn, NY 11219 (the
“Plan Agent”). As Plan Agent, AST keeps records, sends
statements of account to Plan participants and performs other
duties relating to the Plan.
Under
the Plan, you can make an initial investment in Zion’s Common Stock
or Units, or a combination of both, with an initial payment of $250
or more. Once you are a registered shareholder, you can increase
your holdings of our Common Stock or Units (while the Units
continue to be offered) through optional monthly cash payments of
$50 or more.
Investments
in excess of $10,000 in any month or an initial investment in
excess of $10,000 can only be made with our approval and if
necessary by a written “Request for Waiver.” See Question 13. The
dollar limitation of $10,000 and the approval of the “Request for
Waiver” for amounts in excess of $10,000 do not apply to Unit
purchases.
Shares
Generally Recorded Daily
Checks,
bank wire payments, or electronic bank payments for purchases
received by the Plan Agent, or at the offices of the Company,
before 12 noon (EST) on a business day generally will be recorded
as purchased on the same business day (the “Purchase Date”). The
Plan Agent has online interactive purchase facilities
(www.amstock.com) to handle electronic enrollment and electronic
check processing. In addition, the same electronic services are
offered through the Company’s website (www.zionoil.com). Checks,
bank wire payments, or electronic bank payments for purchases
received by the Plan Agent, or at the offices of Company, after 12
noon (EST) on a business day generally will be recorded as
purchased on the next business day for the Purchase Date.
Electronic bank payments are treated as received and recorded on
the date of receipt of the funds into the Plan Agent’s or the
Company’s bank account.
Since
only shares are purchased directly from the Company, the investor’s
Plan account will be credited with the number of shares (including
fractional shares, computed to three decimals) of the Company’s
Common Stock that was purchased. The price at which shares will be
deemed purchased and credited to the investor’s account will be at
the average of the high and low sale prices of the Company’s
publicly traded Common Stock as reported on the OTCQX or any other
exchange or securities market on the Purchase Date. Transaction
confirmations are communicated daily by the Plan Agent and also
quarterly and year-end statements are mailed by the Plan
Agent.
Electronic
Enrollment and Payment Procedures
For
Automated Clearing House debits (ACH) withdrawals that have been
set up by the Plan Agent, the Plan Agent would debit a bank
account. We have successfully implemented an electronic enrollment
procedure with the Telecheck Internet Check Acceptance service as a
payment method. In addition to the enrollment procedures otherwise
specified with the mailing to the Plan Agent of the signed Plan
Enrollment Form and check payment, current stockholders and
prospective investors may enroll in the Plan by the procedures that
allow for an acceptance of an electronic signature and date to the
Plan Enrollment Form and a secure internet check acceptance by
First Data/Citibank Merchant Services as coordinated with the Plan
Agent.
Electronic
enrollment and payment procedures have expanded, in which AST can
accept electronic enrollment and electronic bank payments in U.S.
Dollars and international shareholders and investors can make
payments in British Pounds, Euros, Swiss Francs, or Canadian
Dollars for DSPP purchases through the Company as coordinated with
AST. Funds received in foreign currency will be recorded by AST in
US Dollars based upon the New York Closing Foreign Exchange Rate
(5:00 p.m. EST) on the Purchase Date as published online in the
Wall Street Journal, Market Data Center under Currencies
(www.wsj.com/mdc).
Automatic
Monthly Investments
If
you elect this option, your funds will be debited from your bank
account on the 25th day of each month (the “Purchase
Date”). If the 25th day of the month is a weekend or
holiday, the debit date will be the next succeeding business day.
The price at which shares will be deemed purchased and credited to
the investor’s Plan account will be at the average of the daily
averages of the high and low sale prices of the Company’s publicly
traded Common Stock as reported on the OTCQX or any other exchange
or securities market for the five trading day period ending on the
Purchase Date (hereinafter the “Market Price of the Publicly Traded
Stock”). You may change the amount of funds to be deducted or
terminate an automatic monthly investment of funds by either
accessing your account online (www.amstock.com) or by completing
and submitting to AST a new automatic investment form.
Obtaining
Certificates and Transferring or Selling Shares
Initially,
all shares that are purchased will be held by the Plan Agent and
reflected in book-entry form in the shareholder’s account on the
records of the Plan Agent. A shareholder may request a certificate
(at no cost) for some of or all whole shares (or issuable warrants)
at any time by a request to the Plan Agent by internet
(www.amstock.com), calling 1-844-699-6645 (International
1-718-921-8205), or sending in the form attached to the DSPP
account statement. Certificates are normally issued within three
business days after receipt of the request and mailed no later than
the day after the issuance. No certificates will be issued for
fractional shares; instead, the market value of any fractional
share will be paid in cash.
You
may transfer (at no cost) ownership (or make gifts) of some or all
shares (or issuable warrants) held through the Plan Agent by
calling the Plan Agent at 1-844-699-6645 (International
1-718-921-8205) for complete transfer instructions, or online at
(www.amstock.com/shareholder/ sh_transfinst.asp). The transfer form
must be completed, signed and returned to American Stock Transfer
& Trust Company, LLC, 6201 15th Avenue, Brooklyn, NY
11219. The Medallion Guarantee form may be downloaded from
www.amstock.com/shareholder/sh_downloads.asp.
You
may sell shares through the Plan Agent by accessing www.amstock.com
on the internet, by calling the Plan Agent at 1-844-699-6645
(International 1-718-921-8205), or by mailing the form attached to
the DSPP account statement to the Plan Agent. On receipt of a
request to sell some of or all the Plan shares, the Plan Agent will
sell the shares on the open market no later than three business
days after receipt of the request and will send the proceeds less a
service charge of $5 and applicable brokerage commissions of only
$0.03 per share sold (e.g., if 100 shares sold, commission is $3).
All sell orders received by the Plan Agent by noon Eastern Time
will result in shares being sold the next business day. Sell orders
received after noon Eastern Time will result in shares being sold
the second business day after receipt. The market value of any
fractional share will be paid in cash. Proceeds are normally paid
by check, which is distributed within five business days after the
sale. Tradable warrants will be treated the same above as shares
with respect to obtaining certificates and transferring or selling
warrants.
DSPP
Transaction Processing: |
General
Mailing Inquires: |
|
|
Zion Oil & Gas,
Inc. |
Zion Oil & Gas,
Inc. |
c/o American Stock Transfer &
Trust Co., LLC |
c/o American Stock Transfer &
Trust Co., LLC |
Plan Administration
Department |
6201 15th
Avenue |
Post Office Box 922 |
Brooklyn, NY 11219 |
Wall Street Station |
Domestic (844)
699-6645 |
New York, NY
10269-0560 |
International (718)
921-8205 |
|
www.amstock.com |
Domestic
and Foreign Multi-Lingual Call Center
If
you have any questions about the DSPP, resident shareholders and
investors of the United States and Canada can call the Plan Agent
toll free at 1-844-699-6645 (844-MYZNOIL) and other foreign
resident shareholders and investors can call the Plan Agent at
1-718-921-8205. Customer service representatives with multi-lingual
capability for both domestic and foreign callers are available
between the hours of 8:00 a.m. and 8:00 p.m. EST, Monday through
Friday. After hours, all calls will be forwarded to the AST
automated line 24 hours a day, seven days a week.
Purchasing
Shares under the Plan
Your
Plan account will be credited with the number of shares (including
fractional shares, computed to four decimals) of our Common Stock
that you purchased. Management may, in its sole discretion,
determine to provide a discount off the Market Price of the
Publicly Traded Stock, which will in no event exceed 10% off Market
Price of the Publicly Traded Stock. Zion shall have the sole
discretion to determine, if there is to be a discount, the amount
of such discount, if any (the “Discount Amount”), and the period in
which such discount is to remain in effect (the “Discount Period”).
The Discount Period and the Discount amount will be posted on the
Zion website and the Plan Agent’s website at least two business
days prior to the next succeeding Purchase Date. Modifications of
the Discount Amount and the Discount Period will become effective
on such succeeding Purchase Date following the announcement of such
change.
As a
participant, you are required to have your Common Stock held in
book entry in the Plan with the Plan Agent during the initial six
(6) months after the date of your purchase of any discounted
shares. Any shares withdrawn from the Plan Account within six
(6) months after the date of purchase will be subject to a
withdrawal fee equal to the discount to the Market Price of the
Publicly Traded Stock that you received, if any, when purchasing
the shares being withdrawn, if any discount.
Subject
to compliance with all applicable laws, you may transfer ownership
of some or all of your Plan shares by sending the Plan Agent
written, signed transfer instructions and acceptable to the Plan
Agent and endorsed by the Participant with a medallion guarantee
applied to the endorsement. You will be responsible for
any applicable taxes in connection with the
transfer.
You
will also be credited with dividends on fractions of shares you
hold in the Plan. You can elect to reinvest all or a portion of
your dividends. To date, Zion has not paid dividends on its
common stock and no assurance can be given as to when, if ever,
Zion will be able to pay dividends on its common
stock.
Purchasing
Units under the Plan
The
Plan provides a feature whereby new investors and existing
stockholders may also purchase, directly from Zion, Units of Zion
securities, with each Unit consisting of (i) one or more shares of
our Common Stock and (ii) one or more warrants to purchase
additional shares of our Common Stock.
The
Unit will be offered directly to Plan participants at a price per
Unit to be fixed periodically by Zion. Changes to the per Unit
purchase price will be posted on the Zion website and the Plan
Agent’s at least two business days prior to next succeeding
Purchase Date. No changes will be made to the Warrant exercise
price, which will be fixed at a price per share at the time of the
Unit offering.
The
Warrants to be issued as part of Units purchased under the Plan may
be separately transferable following their issuance and through
their expiration date. The Warrants will remain a book-keeping
entry by the Plan Agent until the Participant requests delivery of
the certificate representing the Warrant. The Warrants will become
first exercisable on the 31st day following the Unit
Option Termination Date and continue to be exercisable through the
expiration date. The Warrants are not exercisable prior to such
date. We may file an application with OTCQX or any other exchange
or securities market to list the Warrants; however, no assurance
can be provided that any warrants will be approved for listing on
any exchange or securities market.
Unlike
shares purchased under the Plan, share of Common Stock and the
Warrants purchased as part of the Units are not subject to the
mandatory deposit requirement, nor to the Withdrawal
fee.
Federal
Income Tax Considerations
Since
you may be purchasing shares at a discount to fair market value,
you may be treated as having received an additional dividend
distribution equal to the excess, if any, of the fair market value
of the shares acquired on the Purchase Date over the amount of your
investment. Generally, participants in the Plan should not
recognize income or loss for United States federal income tax
purposes in connection with the purchase of Units under the Plan.
You should consult your tax advisor as to the particular
consequences to you of the Plan and any future dividend
reinvestment. For a detailed discussion, see “Certain U.S. Federal
Income Tax Consequences” on Page S-31.
DESCRIPTION OF THE
PLAN
The
following is a detailed description of the Plan in
question-and-answer format.
PLAN
OVERVIEW
1. |
What
is the purpose of the Plan?
|
The Plan
provides Zion with an economical and flexible mechanism to raise
equity capital through sales of our Common Stock and Units.
We will be using these proceeds to further our operations,
including our exploration for oil and gas in onshore
Israel.
The
Plan is also intended to promote long-term stock ownership among
existing and new investors in Zion by providing a convenient and
economical method to purchase shares of our Common Stock and
reinvest cash dividends in shares of common stock (when we pay
dividends in the future, if ever) without payment of a brokerage
commission.
The
Plan is designed for long-term investors who wish to invest and
build their share ownership over time. The Plan is not intended to
provide holders of shares of Common Stock with a mechanism for
generating assured short-term profits through rapid turnover of
shares acquired at a discount. The Plan’s intended purpose
precludes any person, organization or other entity from
establishing a series of related accounts for the purpose of
conducting arbitrage operations and/or exceeding the optional
monthly cash investment limit. We reserve the right to modify,
suspend or terminate participation in this Plan by otherwise
eligible holders of our Common Stock or new investors in order to
eliminate practices that we determine, in our sole discretion, to
be inconsistent with the purposes of the Plan or that could
reasonably be used to circumvent the rules of the Plan.
2. |
What
features does the Plan offer?
|
Initial
investment. If you are not an existing shareholder with a Plan
Account through the Plan Agent, you can make an initial investment
in Zion’s Common Stock, starting with as little as $250. If you
wish to make initial cash investments in excess of $10,000 for the
purchase of stock, you will need to obtain our approval and if
necessary a written “Request for Waiver.” See Question
13.
If
you wish, you can also apply this amount to the purchase of Units,
so long as the Units are available for purchase. Please note that
the dollar limitation of $10,000 and the approval and the “Request
for Waiver” for amounts in excess of $10,000 do not apply to Unit
purchases.
Optional
monthly cash investments. Once you are a registered shareholder
with a Plan Account through the Plan Agent, you can increase your
holdings of our Common Stock through optional monthly cash
investments of $50 or more. Participants are not required to make
additional investments. You can make optional monthly cash
investments by check, or electronically with deductions from your
personal bank account. If you wish to make monthly cash investments
in excess of $10,000 for the purchase of stock, you will need to
obtain our prior approval. See Question 13.
For
monthly automatic cash purchases, participants must complete the
Enrollment Form, checking the box for Automatic Monthly
Investments, indicate the amount of the monthly debit (minimum $50,
maximum $10,000 (unless you obtain our prior approval)) and include
a voided check for the account to be debited. Only accounts at U.S.
banks can participate in this program.
Checks
drawn on U.S. banks must be received at least three business days
before the Purchase Dates. Purchases of shares and/or Units are
recorded daily (the “Purchase Date”). For ACH withdrawals that have
been set up by the Plan Agent, the Plan Agent would debit the bank
account only on the 25th of the month.
You
can also apply these amounts to the purchase of Units, as long as
the Units are available for purchase under the Plan. Please note
that the dollar limitation of $10,000 and the approval and the
“Request for Waiver” for amounts in excess of $10,000 do not apply
to Unit purchases.
Automatic
dividend reinvestment. You can also increase your holdings of
our Common Stock through automatic reinvestment of your cash
dividends (when and if dividends are paid in the future). You will
also be credited with dividends on fractions of shares you hold in
the Plan. You can elect to reinvest all or a portion of your
dividends. However, Participants electing to reinvest dividends are
required to reinvest at least 10% of the dividend to qualify as a
dividend reinvestment program under I.R.S. Regulations. To date,
Zion has not paid dividends on its common stock and no assurance
can be given as to when, if ever, Zion will be able to pay
dividends on its common stock.
Mandatory
Share Deposit for Discounted Shares. As a participant, you are
required to have your Common Stock held in book entry form in the
Plan with the Plan Agent for at least six (6) months after the date
of purchase of your shares for any discounted shares. Any
discounted shares withdrawn from the Plan Account within six (6)
months after the date of purchase will be subject to a withdrawal
penalty. See Question 18.
You
are not required to deposit shares of Common Stock and Warrants
that are purchased as part of a Unit and also you are not subject
to any withdrawal fee for such securities.
Automated
transactions. The Plan Agent does have online interactive
purchase facilities. The Plan Agent does provide the Plan
Prospectus and enrollment forms online. Participants will be able
to view their accounts and statements online.
3. |
How
does the purchase of Units work?
|
We offer for
limited time periods, the opportunity to purchase Units of our
securities where each Unit is comprised of one or more shares of
Common Stock and one or more Common Stock purchase warrants. The
Warrant affords you the opportunity to purchase additional shares
of our Common Stock at a fixed warrant exercise price. The Warrants
would become first exercisable on the 31st day following
the Unit Option Termination Date and continue to be exercisable
through the expiration date at a per share fixed exercise price.
The Warrants would not be exercisable prior to such date. We may
file an application with OTCQX or any other exchange or securities
market to list the Warrants: however, no assurance can be provided
that any warrants would be approved for listing on any exchange or
securities market.
4. |
What
is the price that I will pay for shares of Common Stock under the
Plan?
|
Checks, bank
wire payments, or electronic bank payments for purchases received
by the Plan Agent, or at the offices of the Company, before 12 noon
(EST) on a business day generally will be recorded as purchased on
the same business day (the “Purchase Date”). The Plan Agent has
online interactive purchase facilities (www.amstock.com) to handle
electronic enrollment and electronic check processing. In addition,
the same electronic services are offered through the Company’s
website (www.zionoil.com). Checks, bank wire payments, or
electronic bank payments for purchases received by the Plan Agent,
or at the offices of Company, after 12 noon (EST) on a business day
generally will be recorded as purchased on the next business day
for the Purchase Date. Electronic bank payments are treated as
received and recorded on the date of receipt of the funds into the
Plan Agent’s or the Company’s bank account.
The
price at which shares will be deemed purchased and credited to the
investor’s account will be at the average of the high and low sale
prices of the Company’s publicly traded Common Stock as reported on
the OTCQX or any other exchange or securities market on the
Purchase Date.
Any
discount is subject to periodic change by Zion. Zion reserves the
sole discretion to determine any current or future discount off the
Market Price of the Publicly Traded Stock for continuing
investments in shares of our Common Stock. Zion shall have the sole
discretion to determine, if there is to be a Discount Amount, if
any, and the duration of the Discount Period. The Discount Period
and the Discount amount, if any, shall be posted on the Zion
website and the Plan Agent’s website at least two business days
prior to the next succeeding Purchase Date.
Your
Plan account will be credited with the number of shares (including
fractional shares, computed to four decimals) equal to the amount
invested for your Plan account divided by the applicable price per
share.
5. |
What
is the price that I will pay for Units under the
Plan?
|
The Unit
will be offered directly to Plan participants at a price per Unit
to be fixed periodically by Zion. Changes to the per Unit purchase
price will be posted on the Zion website and the Plan Agent’s
website at least two business days prior to the next succeeding
Purchase Date.
6. |
When
will purchases of shares or Units be actually made?
|
Since only
shares are purchased directly from the Company, the investor’s Plan
account will be credited with the number of shares (including
fractional shares, computed to three decimals) of the Company’s
Common Stock that was purchased. The price at which shares will be
deemed purchased and credited to the investor’s account will be at
the average of the high and low sale prices of the Company’s
publicly traded Common Stock as reported on the OTCQX or any other
exchange or securities market on the Purchase Date. Transaction
confirmations are communicated daily by the Plan Agent and also
quarterly and year-end statements are mailed by the Plan
Agent.
Under
dividend reinvestments, the Plan Agent will combine the dividend
funds of all Plan participants whose dividends are automatically
reinvested and will generally invest such dividend funds on the
dividend payment date (and any succeeding trading days necessary to
complete the order). If the dividend payment date falls on a day
that is not a trading day, then the investment will occur on the
next OTCQX or any other exchange or securities market trading day.
In addition, if the dividend is payable on a day when optional cash
payments are to be invested, dividend funds may be commingled with
any such pending cash investments and a combined order may be
executed. The record date associated with a particular dividend is
referred to as the “dividend record date”.
Zion
shall have the sole discretion to determine, if there is to be a
discount to the Market Price of the Publicly Traded Stock. The
Discount Amount, if any, and the duration of the Discount Period
shall be posted on the Zion website and the Plan Agent’s website at
least two business days prior the next succeeding Purchase Date.
Modifications of the Discount Amount and the Discount Period will
become effective on the succeeding Purchase Date following the
announcement of such change.
No
interest will be paid on cash held pending purchase.
7. |
Where
will the shares under the Plan come from?
|
Shares under
the Plan, whether sold directly, or as part of a Unit or issued
upon the exercise of a Warrant, will be purchased directly from
Zion from our pool of authorized and unissued Common
Stock.
Currently,
Zion has reserved approximately 100,000,000 shares of its
authorized and unissued shares of Common Stock to purchases under
the Plan.
ADMINISTRATION
OF THE PLAN
8. |
Who
administers the Plan?
|
The Plan is
administered by American Stock Transfer & Trust Company, LLC
(the “Plan Agent”). The Plan Agent keeps records, sends
statements of account to Plan participants and performs other
duties relating to the Plan. The Common Stock purchased
in your Plan account will be registered in the name of the Plan
Agent. You may, at any time, withdraw all or any part of
the shares held in your Plan account; subject to applicable
withdrawal fees (see Question 18). Special arrangements may be
made with the Plan Agent if you are an institution that is required
by law to maintain physical possession of share
certificates.
Also,
the Plan Agent acts as the warrant agent, receiving Unit purchases,
accepting exercises, issuing common stock and warrants and
forwarding funds when requested.
|
9. |
How
do I contact the Plan Agent or the Company? |
|
Plan Agent |
Company |
Written
Inquiries: |
Zion
Oil & Gas, Inc. |
Zion
Oil & Gas, Inc. |
|
c/o
American Stock Transfer
&
Trust Co., LLC
|
12655
North Central Expressway
Suite
1000
|
|
6201
15th Avenue |
Dallas,
Texas 75243 |
|
Brooklyn,
NY 11219 |
Attn:
Investor Relations |
|
|
invest@zionoil.com |
|
www.amstock.com |
www.zionoil.com |
|
|
|
Phone
Inquiries: |
(844)
699-6645 (Domestic) |
(214)
221-4610 |
|
|
(718)
921-8205 (International) |
|
|
10. |
What
kind of reports will be sent to participants in the
Plan? |
As a Plan
participant, you will receive a statement of your account as soon
as practicable after each transaction (i.e., dividend reinvestment,
optional cash payments, share withdrawals, transfers, Unit
purchases, warrant transactions, etc.) is posted to your Plan
account. You should retain these statements in order to
establish the cost basis of shares and Warrants purchased under the
Plan for income tax and other purposes. In addition, you
will receive copies of all communications sent to all other
shareholders, such as annual and quarterly reports, proxy
statements and income tax information for reporting dividends
paid. Under certain circumstances, in lieu of copies,
you may receive a Notice of Internet Availability of Proxy
Materials providing access to the Company’s proxy statement and
annual report online. The Plan Agent will provide account and
statement information online to investors.
PLAN
ELIGIBILITY AND ENROLLMENT
11. |
Who
is eligible to participate in the Plan?
|
Any person
or legal entity is eligible to participate in the Plan. You do not
have to be a current shareholder, nor do you have to reside or be
located in the U.S. or be a U.S. citizen. Purchases of shares of
Common Stock or Units through the Plan are usually made in U.S.
currency, drawn on a U.S. bank account or by a wire in U.S.
currency from a foreign bank account; except, we can handle certain
foreign currency transactions as outlined below.
We
have successfully implemented an electronic enrollment procedure
with the Telecheck Internet Check Acceptance service as a payment
method. In addition to the enrollment procedures otherwise
specified with the mailing to the Plan Agent of the signed Plan
Enrollment Form and check payment, current stockholders and
prospective investors may enroll in the Plan by the procedures that
allow for an acceptance of an electronic signature and date to the
Plan Enrollment Form and a secure internet check acceptance by
First Data/Citibank Merchant Services as coordinated with the Plan
Agent.
Electronic
enrollment and payment procedures have been implemented, in which
AST can accept electronic enrollment and electronic bank payments
in U.S. Dollars and international shareholders and investors can
make payments in British Pounds, Euros, Swiss Francs, Israeli
Shekels, or Canadian Dollars for DSPP purchases through the Company
as coordinated with AST. Funds received in foreign currency will be
recorded by AST in US Dollars based upon the New York Closing
Foreign Exchange Rate (5:00 p.m. EST) on the Purchase Date as
published online in the Wall Street Journal, Market Data Center
under Currencies (www.wsj.com/mdc).
In
addition, before investing in our Common Stock and/or Units, each
participant who resides or is located outside the U.S. is
responsible for reviewing the laws of his or her country of
residence or other applicable laws to determine if there are any
restrictions on his or her ability to invest through the
Plan.
Investors
who are not U.S. persons should keep the following in mind: (1)
they may face tax obligations in their own country on dividends and
company-paid fees; and (2) the enrollment procedure is the same as
for U.S. taxpayers, except that a W-8 tax form must be filed so
that withholding on dividends will be reduced to the Tax Treaty
amount for the resident country of the investor, if there is an
income tax treaty between the United States and the resident
country of the investor .
The
Plan Agent or Zion may refuse to offer the Plan to residents of any
state that may require registration, qualification or exemption of
the securities to be issued under the Plan, or require registration
or qualification of the Plan Agent or any of its officers or
employees as a broker-dealer, a salesperson or an agent, where we
determine, in our sole discretion, that the number of shareholders
or the number of shares held does not justify the expense that we
may incur with respect to effecting sales of our common stock under
the Plan in the state.
|
12. |
How can I participate in the
Plan? |
Current
Shareholders of Record
If you
already hold shares of our common stock registered in your name,
you may join the Plan by returning a completed enrollment form to
the Plan Agent. Your participation will begin promptly after your
signed Enrollment Form is received by the Plan Agent. Once you have
enrolled, your participation will continue automatically until
either you elect to withdraw from the Plan or we terminate the Plan
or your participation in the Plan. However, any Plan discounts
apply only to new purchases under the Plan of Common Stock and/or
Unit purchases and not to existing shareholders depositing current
Common Stock with the Plan Agent.
New
Investors
If
you are not a current shareholder, you may join the Plan by
returning to the Plan Agent a completed enrollment form along with
an initial investment of at least $250, but not more than $10,000
(subject to our right to waive this maximum, see Question 13) for
direct Common Stock purchases.
Along
with the Enrollment Form, the new investor must send a voided check
to have electronic debits processed from your bank account for your
initial investment or send your initial investment by check payable
to the “American Stock Transfer & Trust Company, LLC.” You are
being required to send a voided check to prevent any mistakes that
can be made in submitting the correct account. Electronic
enrollment and payment procedures are in place as another option
for new investors as outlined above.
Beneficial
Owners and Shares Held in “Street Name”
If
you are a beneficial owner of Zion’s Common Stock and your shares
are registered in the name of a bank, broker, trustee or other
agent, you may transfer your shares to a Plan account to enroll in
the dividend reinvestment program by instructing your bank, broker,
trustee or agent to transfer shares into your name and following
the above instructions for Current Shareholders or by following the
above instructions for New Investors.
|
13. |
How
may I invest in excess of $10,000 under the Plan? |
If you want
to make optional monthly cash investments in excess of $10,000 in
any month or an initial investment in excess of $10,000 for direct
Common Stock purchases, you must receive our approval. To obtain
our approval, you must contact us directly and you may be required
to submit a “Request for Waiver” form. You can obtain a Request for
Waiver form on our website or the website of the Plan Agent at
www.amstock.com or by contacting Zion Oil & Gas, Inc., Investor
Relations, 12655 North Central Expressway, Suite 1000, Dallas,
Texas 75243 Upon completion, please send it directly to Zion Oil
& Gas, Inc. for review and approval. Zion shall notify the
investor of approval of the investment and the Plan Agent of
approval and approval of any Waiver as well as the form of the
payment (wire or check). We have the sole discretion to approve or
refuse any request to make an optional monthly cash investment or
initial investment in excess of the maximum amount and to set the
terms of any such optional monthly cash investment or initial
investment. We have the sole discretion to structure the “Request
for Waiver” program in any way with respect to any requirements,
features, terms, or conditions with respect to any
investor.
We
will decide whether to approve a submitted Request for Waiver
within three (3) business days of the receipt of the request. If
you do not receive a response from us in connection with your
request, you should assume that we have denied your request. If a
request is approved, funds must be received no later than 3:00 p.m.
Eastern time, one business day prior to the first day of the
applicable “Pricing Period” (as defined below). We may alter,
amend, supplement or waive, in our sole discretion, the time
periods and/or other parameters relating to optional cash purchases
in excess of $10,000 made by one or more participants in the Plan
or new investors, at any time and from time to time, prior to the
granting of any Request for Waiver.
If we
approve your Request for Waiver, we will notify you promptly. In
deciding whether to approve a Request for Waiver, we will consider
relevant factors, including, but not limited to, the
following:
|
● |
our
need for additional funds; |
|
● |
the
attractiveness of obtaining additional funds through the sale of
common stock as compared to other sources of funds; |
|
● |
the
purchase price likely to apply to any sale of common
stock; |
|
● |
the
shareholder submitting the request; |
|
● |
the
extent and nature of the shareholder’s prior participation in the
Plan; |
|
● |
the
number of shares of common stock held of record by the
shareholder; |
|
● |
the
aggregate number of cash investments and initial investments in
excess of $10,000 for which requests for waiver have been submitted
by all existing shareholders and new investors; and |
|
● |
our
current and projected capital needs. |
If
requests for waiver are submitted for an aggregate amount in excess
of the amount, we are then willing to accept, we may honor such
requests in order of receipt, pro rata or by any other method that
we determine to be appropriate. We may determine, in our
discretion, the maximum amount that an existing shareholder or new
investor may invest pursuant to the Plan or the maximum number of
shares of Common Stock that may be purchased pursuant to a request
for waiver. In addition, we may place reasonable conditions
regarding the form and timing of payment on the granting of any
waiver.
Purchase
Price of Shares for Optional Cash Investments in Excess of
$10,000. Shares purchased pursuant to an approved Request for
Waiver will be purchased directly from us as described herein,
including the establishment of a “Threshold Price” and a “Waiver
Discount,” as more fully described below. If we grant your request
to purchase shares pursuant to a Request for Waiver, there will be
a “Pricing Period,” which will generally consist of one to 15
consecutive separate trading days on the OTCQX or any other
exchange or securities market, to be determined at our discretion.
Each of these separate trading days will be a “Purchase Date,” and
an equal proportion of your optional cash investment will be
invested on each trading day during such Pricing Period, subject to
the qualifications listed below. The “Purchase Price” for shares
acquired on a particular Purchase Date will be equal to 100%
(subject to change as provided below) of the volume weighted
average price, rounded to four decimal places, of our common shares
as reported by OTCQX or any other exchange or securities market for
the trading hours from 9:30 a.m. to 4:00 p.m., Eastern time
(through and including the OTCQX or any other exchange or
securities market closing print), for that Purchase Date. For
example, if a cash investment of $1,000,000 is made pursuant to an
approved Request for Waiver, and the Pricing Period consists of ten
trading days, there would be ten separate investments, each for
$100,000, beginning on the Pricing Period commencement date and
continuing for ten trading days. The number of shares purchased for
each Purchase Date would be calculated by dividing the
proportionate amount of the approved waiver request amount, in this
example $100,000, by the volume weighted average price as reported
by OTCQX or any other exchange or securities market, rounded to
four decimal places, for the trading hours from 9:30 a.m. to 4:00
p.m., Eastern time (through and including the OTCQX or any other
exchange or securities market closing print), for that Purchase
Date, less any Waiver Discount. Plan shares will not be available
to Plan participants until the conclusion of each Pricing Period or
investment, unless we activate the Continuous Settlement Feature
(see below).
The
Plan Agent will apply all optional cash purchases made pursuant to
a Request for Waiver for which good funds are received on or before
the first business day before the Pricing Period to the purchase of
shares of Common Stock on each Purchase Date of the applicable
Pricing Period.
Threshold
Price. For any given Pricing Period, we may establish a minimum
price, or “Threshold Price,” applicable to optional cash purchases
made pursuant to a Request for Waiver. This determination will be
made by us in our discretion after a review of current market
conditions, the level of participation in the Plan, and current and
projected capital needs.
If
established for any Pricing Period, the Threshold Price will be
stated as a dollar amount that the volume weighted average price,
rounded to four decimal places, of our common shares as reported on
the OTCQX or any other exchange or securities market for the
trading hours from 9:30 a.m. to 4:00 p.m., Eastern time (through
and including the OTCQX or any other exchange or securities market
closing print), for each trading day of such Pricing Period (not
adjusted for discounts, if any) must equal or exceed. Except as
provided below, we will exclude from the Pricing Period any trading
day that the volume weighted average price is less than the
Threshold Price. We also will exclude from the Pricing Period and
from the determination of the purchase price any day in which no
trades of our common shares are made on the OTCQX or any other
exchange or securities market. For example, if the Threshold Price
is not met for two of the trading days in a 10 day Pricing Period,
then we will return 20% of the funds you submitted in connection
with your Request for Waiver unless we have activated the Pricing
Period Extension Feature for the Pricing Period (described
below).
Pricing
Period Extension Feature. We may elect to activate for any
particular Pricing Period the “Pricing Period Extension Feature,”
which will provide that the initial Pricing Period will be extended
by the number of days that the Threshold Price is not satisfied, or
on which there are no trades of our common shares reported by OTCQX
or any other exchange or securities market, subject to a maximum of
five trading days. If we elect to activate the Pricing Period
Extension Feature and the Threshold Price is satisfied for any
additional day that has been added to the initial Pricing Period,
that day will be included as one of the trading days for the
Pricing Period in lieu of the day on which the Threshold Price was
not met or trades of our common shares were not reported. For
example, if the determined Pricing Period is 10 days, and the
Threshold Price is not satisfied for three out of those 10 days in
the initial Pricing Period, and we had previously announced at the
time of the Request for Waiver acceptance that the Pricing Period
Extension Feature was activated, then the Pricing Period will
automatically be extended, and if the Threshold Price is satisfied
on the next three trading days (or a subset thereof), then those
three days (or a subset thereof) will become Purchase Dates in lieu
of the three days on which the Threshold Price was not met. As a
result, because there were 10 trading days during the initial and
extended Pricing Period on which the Threshold Price was satisfied,
all of the optional cash purchase will be invested.
Continuous
Settlement Feature. If we elect to activate the Continuous
Settlement Feature, shares of Common Stock will be available to
Plan Participants within three business days of each Purchase Date
beginning on the first trading day in the applicable Pricing Period
and ending on the final trading day in the applicable Pricing
Period, with an equal amount being invested on each such day,
subject to the qualifications set forth above. We may elect to
activate the Continuous Settlement Feature at the time of the
Request for Waiver form acceptance.
Return
of Unsubscribed Funds. We will return a portion of each
optional cash investment, provided the total optional cash
investment is in excess of $10,000, for each trading day of a
Pricing Period or extended Pricing Period, if applicable, for which
the Threshold Price is not met or for each day in which no trades
of our common shares are reported on the OTCQX or any other
exchange or securities market, which we refer to as unsubscribed
funds. Any unsubscribed funds will be returned within three
business days after the last day of the Pricing Period, or if
applicable, the extended Pricing Period, without interest. The
amount returned will be based on the number of days on which the
Threshold Price was not met compared to the number of days in the
Pricing Period or extended Pricing Period. For example, the return
amount in a 10 day Pricing Period will equal one-tenth (1/10) of
the total amount of such optional cash investment (not just the
amount exceeding $10,000) for each trading day that the Threshold
Price is not met or for each trading day in which sales are not
reported.
The
establishment of the Threshold Price and the possible return of a
portion of the investment apply only to optional cash investments
in excess of $10,000. Setting a Threshold Price for a Pricing
Period will not affect the setting of a Threshold Price for any
other Pricing Period. We may waive our right to set a Threshold
Price for any particular Pricing Period.
In
any event, no interest will be paid on returned funds.
Waiver
Discount. We may establish a discount from the market price
applicable to optional cash investments in excess of $10,000 made
pursuant to a Request for Waiver. This discount, which we also
refer at as the “Waiver Discount,” may be between 0% and 10% of the
purchase price and may vary for each Pricing Period and for each
optional cash investment.
The
Waiver Discount will be established at our sole discretion after a
review of current market conditions, the level of participation in
the Plan, the attractiveness of obtaining such additional funds
through the sale of common shares as compared to other sources of
funds, current and projected capital needs and other factors that
we determine in our sole discretion. Setting a Waiver Discount for
a particular Pricing Period shall not affect the setting of a
Waiver Discount for any other Pricing Period. The Waiver Discount
will apply only to optional cash investments of more than $10,000
(or other applicable maximum monthly amount). The Waiver Discount
will apply to the entire optional cash investment and not just the
portion of the optional cash investment that exceeds $10,000. A
Pricing Period is the time period, in which we establish certain
Waiver Discounts to be in effect with a specified discount
amount.
The
above restriction and Waiver Discount apply only to direct stock
purchases. The dollar limitation of $10,000, the Waiver Discount
and the approval of the “Request for Waiver” for amounts in excess
of $10,000 do not apply to Unit purchases.
14. |
Are
there fees associated with enrollment?
|
No. The
Company pays all fees, administrative and other expenses related to
your Plan enrollment. However, you may incur certain charges for
certain other transactions, requests or withdrawals under the Plan.
However, Participants can be subject to an early withdrawal fee on
direct stock purchases at a discounted price and would be
responsible for any brokerage commissions attributable to any open
market sale.
15. |
Are
there special eligibility or enrollment rules applicable to Company
employees?
|
Yes, if you
are a Company employee, you have the additional option of
purchasing shares through automatic payroll
deductions. Employees who participate through the
automatic payroll deduction option may open a Plan account simply
by completing an Enrollment Form and returning it to Zion.
Otherwise, the stock purchase plans are available on equal terms to
all shareholders, new investors and Company
employees.
MANDATORY
BOOK-ENTRY SERVICES
16. |
What
is meant by book-entry shares?
|
All shares
of Zion Oil’s Common Stock that are purchased through the Direct
Stock Plan will be held by the Plan Agent and reflected in
book-entry form in your account on the records of the Plan
Agent. If you hold other Zion Common Stock certificates,
you may also, at any time, deposit those certificates with the Plan
Agent, but the shares represented by the deposited certificates
will not be included in the book-entry form in your Plan account.
Note: The certificates should not be endorsed and the
assignment section should not be completed.
The
Common Stock and Warrants purchased as part of a Unit will also be
held in book-entry form with the Plan Agent, unless a Participant
requests delivery of the certificates representing the Common Stock
and/or Warrants in whole shares with a check representing
fractional shares and/or warrants.
17. |
Are
there any charges associated with this book entry
service?
|
No. There
is no cost to you either for having the Plan Agent hold the shares
purchased for you through the Plan or for depositing with the Plan
Agent the stock certificates you hold for the purpose of adding the
shares to your book-entry share position. However, you
may incur certain charges for certain other transactions, requests
or withdrawals under the Plan.
|
18. |
Are
there fees associated with withdrawing share certificates within
the six month period following purchase of discounted
shares? |
Yes. Any
shares withdrawn from the Plan Account within six (6) months after
the date of purchase will be charged a withdrawal fee equal to the
discount to the Market Price of the Publicly Traded Stock that you
received when purchasing the shares being withdrawn, up to a
maximum of the number of shares purchased at the discounted
price. Shares cannot be transferred within the Plan or gifted
without incurring the same withdrawal fee, whether by act of law or
by voluntary transfer. The Participant is subject to the withdrawal
fee at the time of withdrawal. The withdrawal fee will also apply
to any purchases of shares made at the discounted price through
automatic dividend reinvestment and employee payroll deductions (if
applicable) during the six (6) month period before the date of
withdrawal. The Participant must send in a check for the amount of
the withdrawal fee for the applicable shares being withdrawn from
the Plan, or, alternatively, the Plan Agent is authorized to sell
sufficient whole shares equal to the withdrawal fee and remit the
residual whole shares and cash in lieu of fractional shares to the
requesting Participant.
The
above provisions do not apply to shares of Common Stock and
Warrants purchased as part of a Unit, along with any shares
issuable upon exercise of a Warrant. Also, the above provision does
not apply to any shares purchased without any discount to the
Market Price of the Publicly Traded Stock, or purchased under a
“Request for Waiver” program.
PURCHASE
OF UNITS
|
19. |
Will
the Unit that I purchase under the Plan be
tradable? |
No.
The Units are not tradable. The shares of Common Stock and Warrants
are being sold as part of a Unit solely for convenience sake and
immediately upon purchase the shares of Common Stock and Warrants
are separable and may be traded separately.
|
20. |
Will
the shares of Common Stock and Warrants that I receive from the
Units be tradable on the OTCQX or any other exchange or securities
market? |
Our
common stock is currently traded on the OTCQX under the symbol
“ZNOG”. The Units are non-transferable and will not be
traded. The Common Stock included in the Units will be listed for
quotation on the OTCQX or any other exchange or securities market
under the symbol “ZNOG”.
The
Warrants included in the Units may be separately transferable
following their issuance. The Warrants will become first
exercisable on the 31st day following any Unit Option
Termination Date and continue to be exercisable through the
expiration date at a fixed per share exercise price. The Warrants
would not be exercisable prior to such date. We may file an
application with OTCQX or any other exchange or securities market
to list the Warrants on the OTCQX or any other exchange or
securities market; however, no assurance can be provided that the
warrants would be approved for listing on the OTCQX or any other
exchange or securities market.
The
shares of Common Stock issuable upon exercise of the Warrants would
be immediately tradable upon issuance and would be listed for
quotation on the OTCQX or any other exchange or securities market
under the symbol “ZNOG”, assuming that the registration statement,
as amended, of which this Prospectus Supplement forms a part
remains effective, and that our Common Stock is still listed on the
OTCQX or any other exchange or securities market, at that time.
Such registration statement, as amended, was declared effective by
the SEC on December 15, 2021 and, therefore, expires on the third
anniversary thereof, subsequent to a 180-day grace period. Such
registration statement, as amended, is sometimes referred to herein
as the “registration statement” or the “shelf registration
statement.”
The
Common Stock and Warrants purchased, as part of a Unit will be held
in book-entry form with the Plan Agent, unless a Participant
requests delivery of the certificates representing the Common Stock
in whole shares with a check representing fractional shares and/or
Warrants.
OPTIONAL
CASH PAYMENTS
|
21. |
How
does the cash payment option work? What are the minimum and maximum
amounts for optional cash payments? |
As a Plan
participant, you may (but are not required to) make optional cash
payments at any time in our Common Stock in amounts of at least
$50, subject to a limitation of $10,000, per month, subject to
approval and if necessary a “Request for Waiver” approval for
amounts greater than $10,000 per month.
All
optional cash payments will be invested in our Common Stock on the
25th day of each calendar month and if such day falls on
a holiday or a weekend, then on the next trading day. See Question
6. Interest will not be paid on funds held pending
investment.
|
22. |
How
do I make an optional cash payment? |
Optional
cash payments may be made by sending a personal check, drawn from a
U.S. Bank in US Dollars, or by sending a bank wire in U.S. dollars,
payable to “American Stock Transfer & Trust Co., LLC,” (“AST”)
along with the Enrollment Form. AST can accept electronic
enrollment and electronic bank payments in U.S. Dollars and
international shareholders and investors can make payments in
British Pounds, Euros, Swiss Francs, Israeli Shekels, or Canadian
Dollars for DSPP purchases through the Company as coordinated with
AST. Funds received in foreign currency will be recorded by AST in
US Dollars based upon the New York Closing Foreign Exchange Rate
(5:00 p.m. EST) on the Purchase Date as published online in the
Wall Street Journal, Market Data Center under Currencies
(www.wsj.com/mdc).
If
you elect this option, your funds will be debited from your bank
account on the 25th day of each month (the “Purchase
Date”). If the 25th day of the month is a weekend or
holiday, the debit date will be the next succeeding business day.
The price at which shares will be deemed purchased and credited to
the investor’s Plan account will be at the average of the daily
averages of the high and low sale prices of the Company’s publicly
traded Common Stock as reported on the OTCQX or any other exchange
or securities market for the five trading day period ending on the
Purchase Date (hereinafter the “Market Price of the Publicly Traded
Stock”). You may change the amount of funds to be deducted or
terminate an automatic monthly investment of funds by either
accessing your account online (www.amstock.com) or by completing
and submitting to AST a new automatic investment form.
|
23. |
Will
I be charged fees for optional cash payments? |
No. You will
not be charged any fees in connection with your optional cash
payments. However, you may incur certain charges for
certain other transactions, requests or withdrawals under the
Plan.
|
24. |
How
are payments with “insufficient funds” handled? |
If an
optional cash payment is made by a check drawn on insufficient
funds or incorrect draft information, or the Plan Agent otherwise
does not receive the money, the requested purchase will be deemed
void, and the Plan Agent will immediately remove from your account
any shares already purchased upon the prior credit of such
funds.
ISSUANCE
OF STOCK CERTIFICATES
|
25. |
Will
stock certificates be issued for shares acquired through the
Plan? |
No. Stock
certificates will not be issued for direct purchases of shares of
Common Stock in a Plan account unless a specific request is made to
the Plan Agent.
26. |
How
do I request a stock certificate?
|
Certificates
for full shares held in the Plan may be obtained, without charge,
by writing to the Plan Agent and requesting the issuance of shares
in certificate form with the exception of the Withdrawal Fee in
Question 18, if the Fee applies.
Certificates for fractional shares will not be issued under any
circumstances.
|
27. |
Can
I pledge or assign the shares held in my Plan
account? |
No. Shares
held in your Plan account may not be pledged or
assigned. If you wish to pledge or assign your shares,
you first must write to the Plan Agent and request the issuance of
shares in certificate form, and pay any applicable withdrawal
fees.
GIFTS
AND TRANSFERS OF SHARES
|
28. |
Can
I transfer shares that I hold in the Plan to someone
else? |
Yes. Subject
to compliance with all applicable laws, you may transfer ownership
of some or all of your Plan shares by sending the Plan Agent
written, signed transfer instructions. You will be
responsible for any applicable taxes in connection with the
transfer. However, a new or existing shareholder must sign an
Enrollment Form in order to become a Plan Participant.
You
may transfer shares to new or existing shareholders. The
Participant will be responsible for any brokerage commissions, if
there are any with any sales. If you are opening a new Plan account
for the transferee, you must include a completed Enrollment Form
with the gift/transfer instructions; however, a new Plan account
will not be opened as a result of a transfer of fewer than ten (10)
shares, unless you (i) authorize the reinvestment of dividends on
the shares to be transferred and (ii) include an optional cash
payment with your transfer instructions sufficient to purchase the
remainder of the ten (10) shares required to enroll. The Plan Agent
may charge the Participant a $15 fee for this transfer service,
subject to any applicable Withdrawal Fee in Question 18.
CHANGING
METHOD OF PARTICIPATION AND WITHDRAWAL
|
29. |
How
do I change my method of participation in the Plan? |
You
may change your method of participation at any time by completing a
new Enrollment Form and returning it to the Plan Agent.
|
30. |
How
do I close my Plan account? |
You may
terminate your participation in the Plan by giving written notice
to the Plan Agent. Upon termination, you must elect
either (a) to receive a certificate for the number of whole shares
held in your Plan account and a check for the value of any
fractional share (which value will be based on the closing market
price on OTCQX or any other exchange or securities market of the
Common Stock on the first day that shares of Common Stock are
traded after the withdrawal request is received); or (b) to have
all of the shares in your Plan account sold for you. If
you request that your shares be sold, the Plan Agent will make the
sale in the market, if practicable, within ten (10) trading days
after receipt of the request. You will receive the
proceeds of sale, less any brokerage commission and transfer tax.
Receipt by the Plan Agent of due notice of a participant’s death or
incompetence shall be deemed a notice of
withdrawal. Medallion Signature Guarantee is required
for sale requests of $10,000 or higher. Because the Plan
Agent will sell shares, on behalf of the Plan, neither the Company
nor any participant under the Plan has the authority or power to
control the timing or pricing of sales, or the selection of the
broker dealer making the sales. Therefore, you will not
be able to precisely time your sales through the Plan, and will
bear the market risk associated with fluctuation in the price of
the Company’s Common Stock. The price of the Common
Stock could go up or down before the broker sells your
shares. In addition, you will not earn interest on any
cash proceeds generated by a sales transaction for your
account.
Any
certificates issued upon termination will be issued in the name or
names in which the account is registered, unless otherwise
instructed. If the certificate is to be issued in a name
other than the name or names on your Plan account, your signature
(and that of any co-owner) on the instructions or stock power must
be “Medallion Guaranteed” by a financial institution participating
in the Medallion Guarantee program. You will be responsible for any
applicable taxes in connection with the transfer. No
certificates will be issued for fractional shares. The Participant
is responsible for any brokerage commissions.
The
Plan Agent will process notices of withdrawal and send proceeds to
you as soon as practicable, without interest. If a
notice of withdrawal is received on or after an ex-dividend date
but before the related dividend payment date, the withdrawal will
be processed as described above and a separate dividend check will
be mailed as soon as practicable following the payment
date. Thereafter, cash dividends will be paid out to the
shareholder and not reinvested in Company Common Stock.
If a
notice of withdrawal is received by the Plan Agent at least two (2)
days prior to an optional cash payment purchase date, any optional
cash payment held by the Plan Agent will be returned to you as soon
as practicable.
Signatures
of all registered holders must be “Medallion Guaranteed” by a
financial institution participating in the Medallion Guarantee
program for all sale requests. The Medallion Guarantee program
ensures that the individual signing is in fact the owner as
indicated on the participant’s account.
Participants
may request the Plan Agent to sell shares in the open market online
at www.amstock.com by acquiring a user ID and password from the
Plan Agent, or they may fax or mail a written request to the Plan
Agent at: American Stock Transfer & Trust Company, LLC, 6201
15th Avenue, Brooklyn, New York 11219, (844) 699-6645
(Domestic), (718) 921-8205 (International).
Plan
withdrawals made within six (6) months after a purchase at a
discounted price described in the answer to Question 18 are subject
to the withdrawal fee explained in that answer.
DIVIDEND
REINVESTMENT
To
date, Zion has not paid any dividends on shares of its common stock
and no assurance can be given as to when, if ever, Zion will be
able to pay dividends on its common stock. The payment of dividends
on our common stock is at the discretion of our Board of Directors.
There is no guarantee that we will pay ever pay dividends in the
future. The timing and amount of future dividends, if any, will
depend on earnings, cash requirements, our financial condition,
applicable government regulations and other factors deemed relevant
by our board.
|
31. |
What
dividend reinvestment options are available in the
Plan? |
(a) “Full
Dividend Reinvestment” - Under this option, you direct the Company
to reinvest the dividends on all of the shares of Common Stock
registered in your name, as well as shares credited to your account
under the Plan. In addition, you may make additional investments by
making optional cash payments; or
(b) “Partial
Dividend Reinvestment” - Under this option, you direct the Company
to reinvest a percentage of the dividends paid on all the shares of
Common Stock registered in your name. The Participant must
reinvest at least 10% of the dividend to qualify under a dividend
reinvestment program as required by the I.R.S. Cost Basis
Regulations. Dividends on shares credited to your account
under the Plan will be reinvested fully. In addition,
you may make additional investments by making optional cash
payments; or
(c) “Optional
Cash Payments Only” - Under this option, you may participate in the
Plan by making optional cash payments only. The Plan
Agent will continue to pay cash dividends on the shares you hold
outside the Plan. Dividends on shares credited to your
account under the Plan (i.e., through the optional cash
investments) will be reinvested fully.
The
Plan Agent will return your Enrollment Form to you if you fail to
select one of these options or fail to sign the Enrollment
Form.
|
32. |
Must
my dividends be reinvested automatically to the extent I have
chosen either Full Dividend Reinvestment or Partial Dividend
Reinvestment? |
Yes. To the
extent you have elected to participate in the Plan, cash dividends
on those shares that are subject to reinvestment will be reinvested
automatically in additional shares of Common Stock.
|
33. |
When
will my dividends be reinvested and at what price? |
If
you are enrolled in the Plan as of an applicable “record date” for
dividends, either all or part of the dividends on your shares
(depending on which option you have chosen) will be used to
purchase shares of Common Stock as of the applicable dividend
payment dates.
The
price of the Common Stock to be purchased under the Plan is
addressed in Question 4 above.
|
34. |
Will
I be charged fees for participating in the dividend reinvestment
program? |
No. You
will not be charged any fees in connection with the reinvestment of
your dividends under the Plan. However, you will incur
certain charges for certain other transactions, requests or
withdrawals under the Plan.
ADDITIONAL
INFORMATION
|
35. |
How
would a stock split, stock dividend or rights offering affect my
account? |
Any
shares resulting from a stock split or stock dividend paid on
shares held in book entry form for you by the Plan Agent will be
credited to your book-entry position.
Warrants
representing rights on any shares registered in your name and on
shares credited to your Plan account will be credited to your
book-entry position. Warrants are held in book entry form unless
directed otherwise by the Plan Participant.
|
36. |
How
do I vote my Plan shares at shareholders’ meetings? |
As a
Plan participant, you will be sent a proxy statement in connection
with each meeting of the Company’s shareholders, together with a
proxy card representing the shares registered directly in your name
and the whole shares held by the Plan Agent in your Plan
account. This proxy card, when signed and returned, will
be voted as you indicate. If the proxy card is not
returned or if it is returned unsigned, the shares will not be
voted unless you or a duly appointed representative votes in person
at the meeting. As is the case with stockholders not
participating in the Plan, if no instructions are indicated on a
properly signed and returned proxy card, all of the shares
represented by the proxy card will be voted in accordance with the
recommendations of the Company’s management, to the extent
permitted by law.
|
37. |
Can
the Plan be changed or discontinued? |
While the
Company intends at the present time to continue the Plan
indefinitely, the Company reserves the right to amend, suspend,
modify or terminate the Plan at any time. Notice of any
such amendment, suspension, modification or termination will be
sent to all Plan participants. The Plan Agent reserves
the right to resign at any time upon reasonable notice to the
Company in writing. The Company reserves the right to
elect and appoint at any time a new agent including itself or its
nominee to administer the Plan.
Upon
termination of the Plan by the Company, the Company or the Plan
Agent, as the case may be, will return any optional cash payments
not invested and payroll deductions, issue a certificate for whole
shares of Common Stock credited to each account under the Plan, and
make a cash payment for any fractional share credited to each
account.
|
38. |
Who
interprets and regulates the Plan? |
Zion
reserves the right to interpret the Plan as may be necessary or
desirable in connection with the operation of the Plan.
|
39. |
What
are the federal income tax considerations of participation in the
Plan? |
Certain
federal income tax considerations of participation in the Plan are
briefly summarized below under the caption “Certain U.S. Federal
Income Tax Considerations”. This summary is for general information
only and does not constitute tax advice. The information in this
section is based on the Internal Revenue Code of 1986, as amended,
or the Code, Treasury Regulations thereunder, current
administrative interpretations and practices of the Internal
Revenue Service, or the Service, and court decisions, all as of the
date of this prospectus supplement. Future legislation, Treasury
Regulations, administrative interpretations and practices or court
decisions could significantly change the current law or adversely
affect existing interpretations of current law. Any change could
apply retroactively to transactions preceding the date of the
change.
The tax consequences for participants who do not reside in the
United States will vary from jurisdiction to jurisdiction. In the
case of a foreign shareholder whose distributions arc subject to
United States income tax withholding, the amount of the tax to be
withheld will be deducted from the amount of the distribution and
the balance will be reinvested. You are urged to consult your
personal tax advisor to determine the particular tax consequences
that may result from your participation in the Plan.
LIMITATION OF
LIABILITY
IF YOU CHOOSE TO PARTICIPATE IN THE PLAN, YOU SHOULD RECOGNIZE
THAT NEITHER THE COMPANY NOR THE PLAN AGENT CAN ASSURE YOU OF A
PROFIT OR PROTECT YOU AGAINST A LOSS ON THE SHARES THAT YOU
PURCHASE UNDER THE PLAN.
Neither the Company nor the Plan Agent, in administering the Plan,
will be liable for any act done in good faith or for any good faith
omission to act, including without limitation any claim of
liability arising out of failure to terminate a participant’s
account upon such participant’s death or incompetence, the price at
which shares are purchased or sold for the participant’s account,
the times when purchases or sales are made, or fluctuations in the
market value of Company Common Stock. This limitation of
liability will not constitute a waiver by any participant of his or
her rights under the federal securities laws.
Although the Plan provides for the reinvestment of dividends, the
declaration and payment of dividends will continue to be determined
by the Board of Directors of the Company in its discretion,
depending upon future earnings, the financial condition of the
Company and other factors. The amount and timing of
dividends may be changed, or the payment of dividends terminated,
at any time without notice.
SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS
This prospectus supplement and the documents included or
incorporated by reference in this prospectus supplement contain
statements concerning our expectations, beliefs, plans, objectives,
goals, strategies, future events or performance and underlying
assumptions and other statements that are not historical facts.
These statements are “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
You generally can identify our forward-looking statements by the
words “anticipate,” “believe,” “budgeted,” “continue,” “could,”
“estimate,” “expect,” “forecast,” “goal,” “intend,” “may,”
“objective,” “plan,” “potential,” “predict,” “projection,”
“scheduled,” “should,” “will” or other similar words. These
forward-looking statements include, among others, statements
regarding:
|
● |
The going concern qualification in our
consolidated financial statements; |
|
● |
our
liquidity and our ability to raise capital to finance our overall
exploration and development activities within our license
area; |
|
● |
our
ability to continue meeting the requisite continued listing
requirements by OTCQX; |
|
● |
the
outcome of the current SEC investigation against us; |
|
● |
Business interruptions from the COVID-19
pandemic; |
|
● |
our
ability to obtain new license areas to continue our petroleum
exploration program; |
|
● |
interruptions, increased consolidated financial
costs and other adverse impacts of the coronavirus pandemic on the
drilling and testing of our MJ#2 well and our capital raising
efforts; |
|
● |
our
ability to explore for and develop natural gas and oil resources
successfully and economically within our license area; |
|
● |
our
ability to maintain the exploration license rights to continue our
petroleum exploration program; |
|
● |
the
availability of equipment, such as seismic equipment, drilling
rigs, and production equipment as well as access to qualified
personnel; |
|
● |
the
impact of governmental regulations, permitting and other legal
requirements in Israel relating to onshore exploratory
drilling; |
|
● |
our
estimates of the time frame within which future exploratory
activities will be undertaken; |
|
● |
changes in our exploration plans and related
budgets; |
|
● |
the
quality of existing and future license areas with regard to, among
other things, the existence of reserves in economic
quantities; |
|
● |
anticipated trends in our business; |
|
● |
our
future results of operations; |
|
● |
our
capital expenditure program; |
|
● |
future market conditions in the oil and gas
industry |
|
● |
the
demand for oil and natural gas, both locally in Israel and
globally; and |
|
● |
The
impact of fluctuating oil and gas prices on our exploration
efforts |
More specifically, our forward-looking statements include, among
others, statements relating to our schedule, business plan,
targets, estimates or results of future drilling,
including the number, timing and results of wells, the timing and
risk involved in drilling follow-up wells, planned expenditures,
prospects budgeted and other future capital expenditures, risk
profile of oil and gas exploration, acquisition of seismic data
(including number, timing and size of projects), planned evaluation
of prospects, probability of prospects having oil and natural gas,
expected production or reserves, increases in reserves, acreage,
working capital requirements, hedging activities, the ability of
expected sources of liquidity to implement our business strategy,
future hiring, future exploration activity, production rates, all
and any other statements regarding future operations, financial
results, business plans and cash needs and other statements that
are not historical facts.
Such statements involve risks and uncertainties, including, but not
limited to, those relating to our dependence on our exploratory
drilling activities, the volatility of oil and natural gas prices,
operating risks of oil and natural gas operations, our dependence
on our key personnel, factors that affect our ability to manage our
growth and achieve our business strategy, risks relating to our
limited operating history, technological changes, our significant
capital requirements, the potential impact of government
regulations, adverse regulatory determinations, litigation,
competition, the uncertainty of reserve information and future net
revenue estimates, property acquisition risks, industry partner
issues, availability of equipment, weather and other factors
detailed herein and in our other filings with the SEC.
We have based our forward-looking statements on our management’s
beliefs and assumptions based on information available to our
management at the time the statements are made. We caution you that
assumptions, beliefs, expectations, intentions and projections
about future events may and often do vary materially from actual
results. Therefore, we cannot assure you that actual results will
not differ materially from those expressed or implied by our
forward-looking statements.
Some of the factors that could cause actual results to differ from
those expressed or implied in forward-looking statements are
described under “Risk Factors” in this prospectus supplement and
the accompanying base prospectus and described under “Risk Factors”
and elsewhere in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2020 and in our other periodic reports
filed with the SEC. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual outcomes may vary materially from those
indicated. All subsequent written and oral forward-looking
statements attributable to us or persons acting on our behalf are
expressly qualified in their entirety by reference to these risks
and uncertainties. You should not place undue reliance on our
forward-looking statements. Each forward-looking statement speaks
only as of the date of the particular statement, and we undertake
no duty to update any forward-looking statement.
RISK FACTORS
Before making an investment decision, you should carefully consider
the risks described under “Risks Related to our Business” below and
in the applicable prospectus supplement, together with all of the
other information appearing in this prospectus or incorporated by
reference into this prospectus and any applicable prospectus
supplement, in light of your particular investment objectives and
financial circumstances. Our business, financial condition or
results of operations could be materially adversely affected by any
of these risks. The trading price of our securities could decline
due to any of these risk factors, and you may lose all or any part
of your investment.
We are an oil and gas exploration company with no current source
of revenue. Our ability to continue in business depends upon our
continued ability to obtain significant financing from external
sources and the success of our exploration efforts, none of which
can be assured.
During the quarter ended September 30, 2021, there were no material
changes to the risk factors previously reported in our Annual
Report on Form 10-K for the year ended December 31, 2020.
CAPITALIZATION
The following table sets forth a summary of our capitalization on
an historical basis as of December 31, 2020. On December 31, 2020,
there were 237,381,555 issued and outstanding shares of Common
Stock. For purposes of a projecting a possible change in our
capitalization, if a future unit program is offered based upon
previous unit offering programs under the Plan, we are making the
following unit feature assumptions. For the purpose of this table,
we are assuming a hypothetical $1.00 unit price for one share of
common stock and one warrant with an exercise price of $1.00. For
this table, we have assumed that all of the Units that could be
offered under the Plan were purchased (with no shares being
purchased) at a per Unit purchase price of $1.00. However, there
can be no assurance that the $1.00 Units would ever be offered
under the Plan and, if so, would in fact be purchased. You should
read this information in conjunction with our financial statements
and the notes thereto which are incorporated by reference into this
prospectus.
|
|
Amount of Capitalization as of December 31, 2020 |
|
|
|
Actual
($) (thousands)
|
|
|
As Adjusted (1)
($) (thousands)
|
|
|
With Additional
Shares (2)
($) (thousands)
|
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
|
Common stock – par value $0.01 per
share |
|
$ |
2374 |
|
|
|
2374 |
|
|
|
2374 |
|
Additional paid in capital |
|
$ |
245,539 |
|
|
|
295,539 |
|
|
|
345,539 |
|
Deficit
accumulated in development stage |
|
$ |
(212,804 |
) |
|
|
(212,804 |
) |
|
|
(212,804 |
) |
Total
stockholders’ equity and capitalization |
|
$ |
35,109 |
|
|
|
85,109 |
|
|
|
135,109 |
|
(1) Assumes that only Units will be sold (consisting of one
share of Common Stock and one warrant exercisable into one share)
under the Plan and that all Units will be purchased (and that no
shares will be offered direct) at a per Unit purchase price of
$1.00. If and when a new Unit program is offered, we will issue and
file an amendment to this prospectus supplement to update the
foregoing information. Zion has reserved approximately 100,000,000
shares of its authorized and unissued shares of Common Stock to
purchases under the Plan.
(2) Assumes that all of the Warrants included in the Units are
exercised at the per share exercise price of $1.00.
For the purpose of the second table, we have assumed that all of
the shares that could be offered under the Plan were purchased
(with no Units being purchased) at a per share price of $1.00.
However, there can be no assurance that all of the shares that
could be offered will be purchased or that we will be able to sell
the shares at $1.00. You should read this information in
conjunction with our financial statements and the notes thereto,
which are incorporated by reference into this prospectus.
|
|
Amount of Capitalization as of December 31, 2020 |
|
|
Actual
($) (thousands)
|
|
|
As Adjusted (1)
($) (thousands)
|
|
|
With Additional
Shares (2)
($) (thousands)
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
|
|
Common stock - par value $0.01 per
share |
|
$ |
2,374 |
|
|
|
|
|
|
N/A |
Additional paid in capital |
|
$ |
245,539 |
|
|
|
345,539 |
|
|
N/A |
Deficit
accumulated in development stage |
|
$ |
(212,804 |
) |
|
|
(212,804 |
) |
|
N/A |
Total
stockholders’ equity and capitalization |
|
$ |
35,109 |
|
|
|
135,109 |
|
|
N/A |
DETERMINATION OF OFFERING
PRICE
The purchase price for the shares/Units and the exercise price of
the Warrants will be set by our board of directors. In determining
the purchase price, our board of directors considered a number of
factors, including: our business prospects; the need to offer
securities at a price that would be attractive to our investors;
general conditions in the securities market; and the likely cost of
capital from other sources. The purchase price is not intended to
bear any relationship to the book value of our assets or our past
operations, cash flows, losses, financial condition, net worth or
any other established criteria used to value securities, the amount
of proceeds desired, our need for equity capital, the historic and
current market price of our common stock, the historic volatility
of the market price of our common stock, our business prospects,
alternatives available to us for raising equity capital, the
pricing of similar transactions and the liquidity of our common
stock. The price does not necessarily bear any relationship to our
past operations, cash flows, book value, current financial
condition, or any other established criteria for value. You should
not consider the purchase price as an indication of the value of
Zion Oil & Gas or our common stock.
The purchase price for shares of Common Stock purchased under the
Plan will be based on the Market Price of the Publicly Traded
Stock, subject to applicable discounts as set forth herein.
DILUTION
As of December 31, 2020, our net tangible book value was
$43,503,000, or $0.18 per share of common stock. Net tangible book
value is the aggregate amount of our tangible assets less our total
liabilities. Net tangible book value per share represents our total
tangible assets less our total liabilities, divided by the number
of shares of common stock outstanding on December 31, 2020.
Assuming in our hypothetical that only Units are sold and that all
of the Units that are being offered will be sold (even though we do
not anticipate that this will be the case) at a per Unit price of
$1.00, dilution would be calculated as follows. After
giving effect to the issuance of shares of our common stock
included in the Units and before deducting offering expenses),
our net tangible book value would increase to approximately
$93,503,000 and the tangible net book value per share would
increase to $0.39. These figures do not account for any Warrant
exercises, if any that may occur. This represents an immediate
increase in net tangible book value of $0.21 per share to current
shareholders, and immediate dilution of $0.61 per share on new
shares purchased in the Unit or 61%. “Dilution” is determined by
subtracting net tangible book value per share after the offering
from the Unit subscription price paid by investors purchasing the
Units. The following table illustrates this per share dilution to
purchasers of Units in this offering, as illustrated in the
following table:
Assumed public offering price per share of
Unit |
|
|
|
|
|
$ |
1.00 |
|
Net tangible book value per share
before this Offering |
|
$ |
0.18 |
|
|
|
|
|
Increase per share attributable to new shares |
|
$ |
0.21 |
|
|
|
|
|
Adjusted net tangible book value per
share after this Offering |
|
|
|
|
|
$ |
0.39 |
|
Dilution per share for new shares |
|
|
|
|
|
$ |
0.61 |
|
Percentage dilution |
|
|
|
|
|
|
61 |
% |
If the per Unit purchase price is in fact modified, then we will
issue and file an amendment to this prospectus supplement to update
the foregoing information.
Assuming that all Warrants included in such Units are exercised in
these hypothetical calculations at the per share exercise price of
$1.00 (even though we do not anticipate that either such event
would occur even if we offered such a unit program), dilution would
be calculated as follows. After giving effect to the issuance of
additional shares of our Common Stock upon exercise of the
Warrants, our net tangible book value would increase to
approximately $143,503,000 and the tangible net book value per
share would increase to $0.60. This represents an immediate
increase in net tangible book value of $0.42 per share to current
shareholders from previous dilution example, and immediate dilution
of $0.81 per share on new shares purchased or 81%. “Dilution” is
determined by subtracting net tangible book value per share after
the Warrant exercises from the Warrant exercise price of $1.00 then
paid by investors upon exercise of the Warrants. The following
table illustrates this per share dilution to purchasers of Units
following the exercise of the Warrants, as illustrated in the
following table:
Assumed warrant strike price per share of
common stock |
|
|
|
|
|
$ |
1.00 |
|
Net tangible book value per share
after this Offering but before warrant exercise |
|
$ |
0.39 |
|
|
|
|
|
Increase per share attributable to new shares |
|
$ |
0.42 |
|
|
|
|
|
Adjusted net tangible book value per
share after this Offering |
|
|
|
|
|
$ |
0.81 |
|
Dilution per share for new shares |
|
|
|
|
|
$ |
0.19 |
|
Percentage dilution |
|
|
|
|
|
|
19 |
% |
Assuming that all of the shares that are being offered will be sold
(even though we do not anticipate that this will be the case),
dilution would be calculated as follows, after giving effect to the
issuance of all of the shares of our common stock that are being
offered under the Plan at a pre-share purchased price of
$1.00. No assurance can be provided that we will be able to
sell the shares at $1.00. Before deducting offering expenses,
our net tangible book value would increase to approximately
$143,503,000 and the tangible net book value per share would
increase to $0.60. These figures do not account for any Warrant
exercises, if any occur. This represents an immediate increase in
net tangible book value of $0.42 per share to current shareholders,
and immediate dilution of $0.40 per share on new shares purchased.
“Dilution” is determined by subtracting net tangible book value per
share after the offering from the assumed share price of $1.00 paid
by investors. The following table illustrates this per share
dilution to purchasers of Units in this offering, as illustrated in
the following table:
Assumed public offering price per share of
share |
|
|
|
|
|
$ |
1.00 |
|
Net tangible book value per share
before this Offering |
|
$ |
0.18 |
|
|
|
|
|
Increase per share attributable to new shares |
|
$ |
0.42 |
|
|
|
|
|
Adjusted net tangible book value per
share after this Offering |
|
|
|
|
|
$ |
0.60 |
|
Dilution per share for new shares |
|
|
|
|
|
$ |
0.40 |
|
Percentage dilution |
|
|
|
|
|
|
40 |
% |
CERTAIN U.S. FEDERAL INCOME
TAX CONSEQUENCES
THIS DISCUSSION IS INCLUDED FOR YOUR GENERAL INFORMATION ONLY.
YOU SHOULD CONSULT YOUR TAX ADVISOR TO DETERMINE THE TAX
CONSEQUENCES TO YOU IN LIGHT OF YOUR PARTICULAR CIRCUMSTANCES,
INCLUDING ANY STATE, LOCAL AND FOREIGN TAX CONSEQUENCES.
The following summary describes certain United States federal
income tax consequences of participating in the Plan to
participants. This summary is based on current law and regulations
as of the date of this prospectus. Future legislation,
Treasury regulations, administrative interpretations and practices
and/or court decisions may adversely affect the tax considerations
described in this prospectus. Any such change could apply
retroactively to transactions preceding the date of the change. We
have not requested and do not intend to request a ruling from the
IRS regarding the tax consequences associated with participating in
the Plan, and the statements in this prospectus are not binding on
the IRS or any court. Thus, we can provide no assurance that the
tax considerations contained in this summary will not be challenged
by the IRS or will be sustained by a court if challenged by the
IRS. This summary does not discuss any state, local or foreign tax
consequences associated with the participation in the Plan, or the
ownership, sale or other disposition of our stock.
This summary deals only with holders who hold our Common Stock
and/or Warrant as a “capital asset” (generally, property held for
investment within the meaning of Section 1221 of the Code). It does
not address all the tax consequences that may be relevant to you in
light of your particular circumstances. In addition, it does not
address the tax consequences relevant to persons who receive
special treatment under the federal income tax law, except where
specifically noted. Holders receiving special treatment include,
without limitation:
|
● |
financial institutions,
banks and thrifts; |
|
● |
tax-exempt
organizations; |
|
● |
regulated investment companies
and real estate investment trusts; |
|
● |
foreign corporations or
partnerships, and persons who are not residents or citizens of the
United States; |
|
● |
dealers in securities or
currencies; |
|
● |
persons holding our Common Stock
as a hedge against currency risks or as a position in a straddle;
or |
|
● |
United States persons whose
functional currency is not the United States dollar. |
If a partnership holds our Common Stock and/or warrants, the tax
treatment of a partner in the partnership generally will depend
upon the status of the partner and the activities of the
partnership. If you are a partner of a partnership holding our
Common Stock and/or Warrant, you should consult your tax advisor
regarding the tax consequences of participating in the Plan and the
ownership and disposition of our Common Stock and/or warrants.
If you are considering participating in the Plan, you are strongly
urged to consult your tax advisors concerning the application of
United States federal income tax laws to your particular situation,
the consequences of your participation in the Plan, the ownership
and disposition of our Common Stock and/or warrants arising under
the laws of any state, local or foreign taxing jurisdiction.
U.S. Participant
When we use the term “U.S. participant,” we mean a participant in
the Plan who, for United States federal income tax purposes is:
|
● |
a citizen or resident of the
United States; |
|
● |
a
corporation, partnership, limited liability company or other entity
created or organized in or under the laws of the United States or
of any State thereof or in the District of Columbia unless, in the
case of a partnership or limited liability company, Treasury
regulations provide otherwise; |
|
● |
an
estate the income of which is subject to United States federal
income taxation regardless of its source; or |
|
● |
a
trust whose administration is subject to the primary supervision of
a United States court and which has one or more United States
persons who have the authority to control all substantial decisions
of the trust. Notwithstanding the preceding sentence, to the extent
provided in the Treasury regulations, certain trusts in existence
on August 20, 1996, and treated as United States persons prior to
this date that elect to continue to be treated as United States
persons, shall also be considered U.S. participants. |
Direct Stock Purchases
|
● |
A participant who purchases shares
of Common Stock directly (and not as part of a Unit) with the
initial investment and the optional cash payments may be treated as
having received an additional dividend distribution equal to the
excess, if any, of the fair market value of the shares acquired on
the Purchase Date over the amount of your investment. |
|
● |
A participant will not realize any
taxable income when the participant sends Common Stock certificates
to the Plan Agent to be deposited into the participant’s Plan
Account. A participant’s tax basis and holding period for shares of
Common Stock purchased outside the Plan and deposited in the
participant’s Plan Account will be the same as they would have been
had the participant continued to hold those shares outside the
Plan. |
|
● |
A participant will not realize any
taxable income when the participant receives certificates for whole
shares of Common Stock held in the participant’s Plan Account,
either upon request for certificates, or upon termination of
participation or termination of the Plan by us. |
|
● |
A participant will generally
recognize gain or loss when shares of Common Stock acquired under
the Plan (including fractions of shares) are sold by the Plan Agent
at the participant’s request or sold after withdrawal from or
termination of the Plan. A participant who receives, upon
termination of participation or termination of the Plan by us, a
cash adjustment for a fraction of a share credited to the
participant’s account may realize gain or loss with respect to such
fraction. The amount of the gain or loss will be the difference
between the amount which the participant receives for the shares of
Common Stock (or fraction of a share) and the participant’s tax
basis. Such gain or loss will generally be capital gain or loss,
and will be long-term or short-term depending on the holding period
of the shares of Common Stock sold. The capital gain or loss will
be long-term if the participant’s holding period for shares of
Common Stock is more than one year at the time of sale and will be
short-term if the holding period is one year or less. A
participant’s holding period for shares of Common Stock acquired
pursuant to the Plan generally begins on the day following the date
the shares are credited to the participant’s Plan Account. A whole
share consisting of fractional shares purchased on different dates
will have a split holding period with the holding period for each
fractional component beginning on the day following the date the
factional share was credited to the participant’s Plan
Account. |
|
● |
With respect to tax basis
reporting, participants may elect to use the “average basis method”
with respect to shares of stock acquired in connection with certain
dividend reinvestment plans that require the reinvestment of at
least 10% of every dividend. Because the Plan requires the
reinvestment of at least 10% of dividends, a participant may elect
to use the average basis method of determining such tax basis.
Absent an election to the contrary, the Plan Agent intends to use
the “FIFO” method (as defined in applicable Treasury Regulations)
for shares of our Common Stock acquired by or for you under the
Plan. |
|
● |
Certain U.S. participants that are
individuals, estates, or trusts will be subject to a 3.8% Medicare
tax on, among other things, dividends on and capital gains from the
sale or other disposition of stock, subject to certain
exceptions. |
|
● |
As a participant in the Plan, you
will receive statements on a regular basis advising you of
purchases and sales of shares of Common Stock. Any distribution
treated as a dividend (including from brokerage commissions and
fees paid by the Company) will be reported on your year-end IRS
Form 1099-DIV. If, at your request, the Plan Agent sells shares of
Common Stock for you, the proceeds from the sale will be reported
on IRS Form 1099-B. |
Amounts Treated As a Distribution
|
● |
A participant who participates in
the dividend reinvestment feature of the Plan will be treated for
federal income tax purposes as having received a distribution in an
amount equal to the sum of (a) the fair market value of the shares
on the date the shares were acquired directly from us with
reinvested dividends, (b) any cash distributions received by the
Plan Agent for the purpose of acquiring additional shares on your
behalf, and (c) any cash distributions received by you with respect
to shares of common stock not included in the Plan. A participant
who participates in the dividend reinvestment feature of the Plan
and makes an optional cash purchase of shares of common stock under
the Plan will be treated as having received a distribution equal to
the excess, if any, of the fair market value on the investment date
of the common shares over the amount of the optional cash payment
made by the participant. |
|
● |
The Internal Revenue Service has
indicated in private letter rulings (which are applicable only to
the taxpayer to whom the ruling is issued) that a taxpayer who does
not participate in the dividend reinvestment feature of the Plan
and only makes an optional cash purchase of common stock under the
Plan will not be treated as having received a distribution equal to
the excess, if any, of the fair market value on the investment date
of the shares of Common Stock over the amount of the optional cash
payment made by the taxpayer. |
|
● |
The total amount of your
distributions will be reported to you and to the Internal Revenue
Service on the appropriate tax form shortly after the end of each
year by the Plan Agent. |
Character of Distributions
|
● |
The amount treated as distributions
to shareholders as described above constitute dividends for federal
income tax purposes up to the amount of our positive current and
accumulated earnings and profits and, to that extent, will be
taxable as ordinary income. |
|
● |
To the extent distributions are in
excess of our earnings and profits, the distributions will be
treated first as a tax-free return of capital to the extent of your
tax basis in our common shares and, to the extent in excess of your
basis, will be taxable as a gain realized from the sale of your
common shares. |
|
● |
Distributions to corporate
shareholders, including amounts taxable as dividends to corporate
shareholders, will not be eligible for the corporate dividend
received deduction. |
Tax Basis and Holding Period of Shares and Warrants Acquired
Pursuant to the Plan
|
● |
Your tax basis in shares of common
stock acquired directly from us with reinvested cash distributions
under the Plan will be equal to the fair market value of such
shares as of the date of distribution. Your tax basis in additional
common shares acquired under the Plan with optional cash
investments should be equal to the amount of such optional cash
investments plus the amount, if any, treated as a distribution to
you. Your tax basis in shares of common stock purchased on your
behalf by the Plan Agent in the open market or privately negotiated
transactions will be equal to the cost of such shares plus your
proportionate amount of commission paid by us as in connection with
such purchase. |
|
● |
Your tax basis in the common stock
and the warrant acquired from the Unit program will be allocated to
each element of the Unit on the basis of their respective fair
market values on the date of purchase. If the fair market value of
the warrant is not readily ascertainable then the portion of the
price paid of the Unit will be allocable first to the Common Stock
to the extent of the fair market price of the Common Stock on the
date of Unit purchase with the remaining purchase price allocated
to the warrant. |
|
● |
Your holding period for shares of
common stock acquired with reinvested cash distributions generally
will commence on the day after the dividend payment date. If,
however, the shares are acquired with optional cash investments or
are purchased with reinvested cash distributions by the Plan Agent
on your behalf, the holding period will commence on the day after
the date of purchase. |
|
● |
Your holding period for the Common
Stock and the Warrant purchased under the Unit program will
commence for both securities on the day after the date of purchase
of the Unit. |
|
● |
Your holding period for the Common
Stock issuable upon exercise of a Warrant will commence on the day
after you exercise the Warrant and pay the exercise price. |
Effect of Withholding Requirements
|
● |
Under certain conditions, we or the
Plan Agent may be required to deduct as “backup withholding”
twenty-eight (28%) of all dividends paid to you, regardless of
whether such dividends are reinvested pursuant to the Plan. |
|
● |
Similarly, the Plan Agent may be
required to deduct backup withholding from all proceeds from sales
of shares of common stock held in your account. |
|
● |
Backup withholding amounts will be
withheld from dividends before such dividends are reinvested under
the Plan. Therefore, if you are subject to backup withholding,
dividends to be reinvested under the Plan will be reduced by the
backup withholding amount. |
Foreign Shareholder Participation
|
● |
If you are a foreign shareholder,
you need to provide the required federal income certifications to
establish your status as a foreign shareholder so that backup
withholding as described above does not apply to you. |
|
● |
You also need to provide the
required certifications, if you wish to claim the benefit of
exemptions from federal income tax withholding or reduced
withholding rates under a treaty or convention entered into between
the United States and your country of residence. |
|
● |
If you are a foreign shareholder
whose dividends are subject to federal income tax withholding, the
appropriate amount will be withheld and the balance in shares of
common stock will be credited to your account. |
|
● |
Dividends and sales proceeds
payable to certain foreign shareholders will be subject to special
reporting rules under “FATCA.” If these rules are not complied
with, such dividends and sales proceeds will be subject to
withholding tax at a rate of 30% in spite of a treaty that provides
a lower rate. Such withholding applies to dividends paid in respect
of our Common Stock and to gross proceeds from the sale or other
disposition of our Common Stock. If withholding is required under
these rules, the appropriate amount of tax will be deducted and
only the remaining amount will be reinvested or paid. |
IRS CIRCULAR 230 DISCLOSURE. TO ENSURE COMPLIANCE WITH INTERNAL
REVENUE SERVICE CIRCULAR 230, PARTICIPANTS ARE HEREBY NOTIFIED
THAT: (I) ANY DISCUSSION OF FEDERAL TAX ISSUES IN THIS PROSPECTUS
WAS NOT INTENDED OR WRITTEN TO BE RELIED UPON, AND CANNOT BE RELIED
UPON BY PARTICIPANTS FOR THE PURPOSE OF AVOIDING PENALTIES THAT MAY
BE IMPOSED ON PARTICIPANTS UNDER THE INTERNAL REVENUE CODE OF 1986,
AS AMENDED; (II) SUCH DISCUSSION IS WRITTEN IN CONNECTION WITH THE
PROMOTION OR MARKETING OF THE TRANSACTIONS OR MATTERS ADDRESSED IN
THIS PROSPECTUS; AND (III) PARTICIPANTS SHOULD SEEK TAX ADVICE
BASED ON THEIR PARTICICULAR CIRCUMSTANCES FROM AN INDEPENDENT TAX
ADVISOR.
USE OF PROCEEDS
Shares purchased for Plan participants with reinvested cash
dividends and optional cash investments and through Unit purchases
will be shares newly issued by Zion. Zion and the Plan Agent
are unable to estimate the number of shares, if any, that will be
purchased directly from the Company under the Plan or the amount of
proceeds from any such shares. The net proceeds will be
used by the Company for general corporate purposes.
PLAN OF DISTRIBUTION
Subject to other provisions within this Prospectus Supplement and
the accompanying base Prospectus, we will distribute newly issued
shares of our Common Stock and/or the Warrants sold under the Unit
Plan if requested by the purchaser to the Plan Agent. Under direct
stock purchases, the Plan Agent will maintain the Common Stock on
deposit for the initial six (6) months after the date of purchase
and continuing until there is a request for withdrawal of the
discounted shares by the owner or owners. The Plan Agent will
assist in the administration of the Plan, but will not be acting as
an underwriter with respect to shares of our common stock sold
under the Plan. You will pay no service fees or brokerage trading
fees for acquisitions of shares under the Plan, whether the shares
are newly issued or purchased in the open market. Our
common stock is currently listed on the OTCQX under the symbol
“ZNOG,” but may be listed on any other exchange or securities
market.
In connection with the administration of the Plan, we may be
requested to approve investments made pursuant to requests for
waiver by or on behalf of existing stockholders and new investors
who may be engaged in the securities business.
Persons who acquire shares of our Common Stock through the Plan and
resell them shortly after acquiring them, including coverage of
short positions, under certain circumstances, may be participating
in a distribution of securities that would require compliance with
Regulation M under the Exchange Act, and may be considered to be
underwriters within the meaning of the Securities Act of 1933. We
will not extend to any such person any rights or privileges other
than to which he, she or it would be entitled as a participant, nor
will we enter into any agreement with any such person regarding the
resale or distribution by any such person of the shares of our
Common Stock so purchased. We may, however, accept optional cash
payments and initial investments made pursuant to requests for
waiver by such persons.
From time to time, financial intermediaries, including brokers and
dealers, and other persons may engage in positioning transactions
in order to benefit from any discounts applicable to optional cash
payments and initial investments made under the Plan. Those
transactions may cause fluctuations in the trading volume of our
Common Stock. Financial intermediaries and such other persons who
engage in positioning transactions may be deemed to be
underwriters. We have no arrangements or understandings, formal or
informal, with any person relating to the sale of shares of our
Common Stock to be received under the Plan. We reserve the right to
modify, suspend or terminate participation in the Plan by otherwise
eligible persons to eliminate practices that are inconsistent with
the purposes of the Plan.
LEGAL MATTERS
Aboudi Legal Group PLLC (Zion’s external legal counsel) will pass
on the validity of the issuance of the securities offered by this
prospectus supplement and the accompanying base prospectus.
EXPERTS
The audited financial statements of Zion Oil & Gas, Inc. as of
December 31, 2020 and management’s assessment of the effectiveness
of internal control over financial reporting as of December 31,
2020 have been incorporated by reference herein in reliance upon
the reports of RBSM LLP, an independent registered public
accounting firm.
WHERE YOU CAN FIND MORE
INFORMATION AND INCORPORATION OF CERTAIN INFORMATION BY
REFERENCE
We file annual, quarterly and current reports, proxy statements and
other information with the SEC. Our filings are available to the
public over the Internet at the SEC’s website at
http://www.sec.gov. You may also read and copy any document we file
with the SEC at its public reference facilities at 100 F Street,
N.E., Washington, D.C. 20549. You can also obtain copies of the
documents at prescribed rates by writing to the Public Reference
Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549.
Please call the SEC at 1-800-SEC-0330 for further information on
the operation of the public reference facilities. Our SEC filings
are also available at no cost on our website,
http://www.zionoil.com/sec-reports, as soon as reasonably
practicable after we file such documents with the SEC. Except for
those SEC filings, none of the other information on our website is
part of this prospectus supplement or the accompanying base
prospectus.
We “incorporate by reference” into this prospectus supplement and
the accompanying base prospectus the information that we file with
the SEC, which means that we can disclose important information to
you by referring you to those documents. The information
incorporated by reference is an important part of this prospectus
supplement and the accompanying base prospectus. Some information
contained in this prospectus supplement and the accompanying base
prospectus updates the information incorporated by reference, and
information that the Company files subsequently with the SEC will
automatically update this prospectus supplement and the
accompanying base prospectus. In other words, in the case of a
conflict or inconsistency between information set forth in this
prospectus supplement, the accompanying base prospectus, and the
information incorporated by reference herein, you should rely on
the information contained in the document that was filed last. We
incorporate by reference the following documents (excluding any
portions of such documents that have been “furnished” but not
“filed” for purposes of the Securities Exchange Act of 1934, as
amended, which we refer to as the “Exchange Act”):
|
● |
Our
annual report on
Form 10-K for the fiscal year ended December 31, 2020
filed on March 24, 2021; |
|
● |
Our
definitive proxy statement with respect to the Annual Meeting
of Stockholders held on June 9, 2021, as filed with the Securities
and Exchange Commission on April 15, 2021; |
|
● |
the
description of our common stock in our registration statement on
Form 8-A filed with the SEC on December 29, 2006, including any
amendments or reports filed for the purpose of updating such
description; and the description of our 10% Convertible Senior Note
due 2021 on
Form 8-A/Afiled with the SEC on April 28, 2016; and |
|
● |
all
future filings that we make with the SEC under Section 13(a),
13(c), 14, or 15(d) of the Exchange Act after the date of filing of
the registration statement on Form S-3, as amended, of which this
prospectus supplement and the accompanying base prospectus are a
part and prior to the termination or completion of any offering of
securities under this prospectus supplement and the accompanying
base prospectus (except, in each case, for information contained in
any such filing that is furnished and not “filed” under the
Exchange Act), which filings will be deemed to be incorporated by
reference in this prospectus supplement and the accompanying base
prospectus, and to be a part hereof from the respective dates of
such filings. |
We will provide without charge to each person, including any
beneficial owner, to whom this prospectus is delivered, upon
written or oral request of such person, a copy of any or all of the
information that is incorporated by reference in this prospectus
supplement and base prospectus. Requests for such documents should
be directed to: Shareholder Relations, Zion Oil & Gas, Inc.,
12655 North Central Expressway, Suite 1000, Dallas, TX 75243.
This prospectus supplement and the accompanying base prospectus are
a part of a registration statement on Form S-3, as amended, that we
filed with the SEC. That registration statement contains more
information than this prospectus supplement and the accompanying
base prospectus regarding us and our common stock, including
certain exhibits and schedules. You can obtain a copy of the
registration statement from the SEC at the address listed above or
from the SEC’s Internet website.
You should rely only on the information in this prospectus
supplement, the accompanying base prospectus, any applicable free
writing prospectus and the documents that are incorporated herein
or therein by reference. We have not authorized anyone else to
provide you with different information. We are not offering these
securities in any state where the offer is prohibited by law. You
should not assume that the information in this prospectus
supplement, the accompanying base prospectus, any applicable free
writing prospectus or any document incorporated by reference into
any of them is accurate as of any date other than the date of the
applicable document.
[This page was intentionally left blank]
Annex A – Enrollment
Form



Annex B – Form of
Warrant
Annex B
[Face of Certificate - ZION OIL & GAS, INC.]
(SEE REVERSE SIDE FOR LEGEND)
W
WARRANTS
(THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 5:00 P.M.,
EASTERN STANDARD TIME,
______________, 20__)
ZION OIL & GAS, INC.
CUSIP 989696 ___
WARRANT
THIS CERTIFIES THAT, for value received _____________ is the
registered holder of a Warrant or Warrants expiring _____________,
20__ (the “Warrant”) to purchase one fully paid and non-assessable
share of Common Stock, par value $.01 per share (the “Shares”), of
ZION OIL & GAS, INC., a Delaware corporation (the “Company”).
The Warrant entitles the holder thereof to purchase from the
Company, commencing on _____, 20__, one Share of the Company at the
price of $___ per share, upon surrender of this Warrant Certificate
and payment of the Warrant Price at the office or agency of the
Warrant Agent, American Stock Transfer & Trust Company, LLC
(such payment to be made by check made payable to the order of the
Company), but only subject to the conditions set forth herein and
in the Warrant Agreement between the Company and the Warrant Agent.
In no event shall the registered holder of this Warrant be entitled
to receive a net-cash settlement or other consideration in lieu of
physical settlement in Shares of the Company. The Warrant Agreement
provides that, upon the occurrence of certain events, the Warrant
Price and the number of Warrant Shares purchasable hereunder, set
forth on the face hereof, may, subject to certain conditions, be
adjusted. The term Warrant Price as used in this Warrant
Certificate refers to the price per Share at which Shares may be
purchased at the time the Warrant is exercised.
This Warrant may expire on the date first above written if it is
not exercised prior to such date by the registered holder pursuant
to the terms of the Warrant Agreement.
No fraction of a Share will be issued upon any exercise of a
Warrant. If, upon exercise of a Warrant, a holder would be entitled
to receive a fractional interest in a Share, the Company will, upon
exercise, round up to the nearest whole number the number of shares
of common stock to be issued to the warrant holder.
Upon any exercise of the Warrant for less than the total number of
full Shares provided for herein, there shall be issued to the
registered holder hereof or his/her/its assignee a new Warrant
Certificate covering the number of Shares for which the Warrant has
not been exercised.
Warrant Certificates, when surrendered at the office or agency of
the Warrant Agent by the registered holder hereof in person or by
attorney duly authorized in writing, may be exchanged in the manner
and subject to the limitations provided in the Warrant Agreement,
but without payment of any service charge, for another Warrant
Certificate or Warrant Certificates of like tenor and evidencing in
the aggregate a like number of Warrants.
Upon due presentment for registration of transfer of the Warrant
Certificate at the office or agency of the Warrant Agent, a new
Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants shall be
issued to the transferee in exchange for this Warrant Certificate,
subject to the limitations provided in the Warrant Agreement,
without charge except for any applicable tax or other governmental
charge.
The Company and the Warrant Agent may deem and treat the registered
holder as the absolute owner of the Warrants represented by this
Warrant Certificate (notwithstanding any notation of ownership or
other writing hereon made by anyone) for the purpose of any
exercise hereof, of any distribution to the registered holder, and
for all other purposes, and neither the Company nor the Warrant
Agent shall be affected by any notice to the contrary.
This Warrant does not entitle the registered holder to any of the
rights of a stockholder of the Company.
COUNTERSIGNED:
American Stock Transfer & Trust Company, LLC
WARRANT AGENT
BY:
AUTHORIZED OFFICER
DATED:
(Signature)
CHIEF EXECUTIVE OFFICER
(Seal)
(Signature)
SECRETARY
SUBSCRIPTION FORM
To Be Executed by the Registered Holder in Order to Exercise
Warrants
The undersigned Registered Holder irrevocably elects to exercise
_________ Warrants represented by this Warrant Certificate, and to
purchase the shares of Common Stock issuable upon the exercise of
such Warrants, and requests that Certificates for such shares shall
be issued in the name of
(PLEASE TYPE OR PRINT NAME AND ADDRESS)
(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)
and be delivered to
(PLEASE PRINT OR TYPE NAME AND ADDRESS)
and, if such number of Warrants shall not be all the Warrants
evidenced by this Warrant Certificate, that a new Warrant
Certificate for the balance of such Warrants be registered in the
name of, and delivered to, the Registered Holder at the address
stated below:
Dated: |
- |
|
|
(SIGNATURE) |
- |
|
|
(ADDRESS) |
- |
|
|
(TAX
IDENTIFICATION NUMBER) |
- |
THE SIGNATURE TO THE ASSIGNMENT OF THE SUBSCRIPTION FORM MUST
CORRESPOND TO THE NAME WRITTEN UPON THE FACE OF THIS WARRANT
CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT
OR ANY CHANGE WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL
BANK OR TRUST COMPANY OR A MEMBER FIRM OF THE AMERICAN STOCK
EXCHANGE, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE OR
CHICAGO STOCK EXCHANGE.
ASSIGNMENT
To Be Executed by the Registered Holder in Order to Assign
Warrants
For Value Received, _____________________hereby sell, assign, and
transfer unto
_____________________________________________________
(PLEASE TYPE OR PRINT NAME AND ADDRESS)
_____________________________________________________
_____________________________________________________
_____________________________________________________
(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)
and be delivered
to__________________________________________________________________________________
(PLEASE PRINT OR TYPE NAME AND ADDRESS)
Of the Warrants represented by this Warrant Certificate, and hereby
irrevocably constitute and
Appoint ________________________________Attorney to transfer this
Warrant Certificate on the books of the Company, with full power of
substitution in the premises.
Dated:
(SIGNATURE)
Notice: The signature to this assignment must correspond with the
name as written upon the face of the certificate in every
particular, without alteration or enlargement or any change
whatever.
Signature(s) Guaranteed:
THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND
CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).
PROSPECTUS
$401,079,888
ZION OIL & GAS, INC.
Common Stock, Debt Securities, Warrants and Units
This prospectus is both (1) a new registration statement and (2) a
replacement registration statement that we filed with the
Securities and Exchange Commission (the “SEC”) using a Form S-1
registration process on December 9, 2019. From time to time, we may
offer up to an aggregate of approximately $401,079,888 of any
combination of the securities described in this prospectus, either
individually or in units. This prospectus provides a general
description of the securities we may offer. Each time we sell
securities, we will provide specific terms of the securities
offered in a supplement to this prospectus. The prospectus
supplement may also add, update or change information contained in
this prospectus. You should read this prospectus and the
applicable prospectus supplement carefully before you invest in any
securities.
Our common stock is quoted on the OTCQX under the symbol “ZNOG.”
The sale price of our common stock on the OTCQX on November 29,
2021 was $0.266 and our public float was approximately $87 million.
Under our Dividend Reinvestment and Common Stock Purchase Plan, we
also have a common stock purchase warrant at an exercise price of
$2.00, expiring January 31, 2023, that was issued and quoted on the
OTCQX under the symbol “ZNOGW to the above and any other listing on
the OTCQX or any securities market or other exchange of the
securities, if any, covered by the prospectus supplement.
Investing in our securities involves a high degree of risk. We
urge you to carefully consider the risks that we have described on
page 11 of this prospectus under the caption “Risk Factors.”
We may also include specific risk factors in supplements to this
prospectus under the caption “Risk Factors.” This prospectus may
not be used to offer or sell our securities unless accompanied by a
prospectus supplement.
We will sell these securities directly to investors, through agents
designated from time to time or to or through underwriters or
dealers. For additional information on the methods of sale, you
should refer to the section entitled “Plan of Distribution” in this
prospectus. If any underwriters are involved in the sale of
any securities with respect to which this prospectus is being
delivered, the names of such underwriters and any applicable
commissions or discounts will be set forth in a prospectus
supplement. The price to the public of such securities
and the net proceeds we expect to receive from such sale will also
be set forth in a prospectus supplement.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE
SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE
SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS
PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.
The date of this prospectus is December 1, 2021.
Table of Contents
ABOUT THIS
PROSPECTUS
This prospectus is both (1) a new registration statement and (2) a
replacement registration statement that we filed with the
Securities and Exchange Commission, or SEC, on December 9, 2019,
utilizing a Form S-1 registration process. Under this shelf
registration process, we may sell any combination of the securities
described in this prospectus in one or more offerings up to a total
dollar amount of approximately $401,079,888. This prospectus
provides you with a general description of the securities we may
offer. Each time we sell securities under this shelf
registration, we will provide a prospectus supplement that will
contain specific information about the terms of that
offering. The prospectus supplement may also add, update or
change information contained in this prospectus. You should
read both this prospectus and any prospectus supplement together
with additional information described on page 29 under the heading
“Where You Can Find More Information.”
You should rely only on the information provided or incorporated by
reference in this prospectus or any prospectus supplement. We have
not authorized any dealer, salesman or other person to give any
information or to make any representation other than those
contained or incorporated by reference in this prospectus and the
accompanying supplement to this prospectus. You must not rely upon
any information or representation not contained or incorporated by
reference in this prospectus or the accompanying prospectus
supplement. This prospectus and the accompanying supplement to this
prospectus do not constitute an offer to sell or the solicitation
of an offer to buy any securities other than the registered
securities to which they relate, nor do this prospectus and
the accompanying supplement to this prospectus constitute an offer
to sell or the solicitation of an offer to buy securities in any
jurisdiction to any person to whom it is unlawful to make such
offer or solicitation in such jurisdiction. You should not assume
that the information contained in this prospectus and the
accompanying prospectus supplement is accurate on any date
subsequent to the date set forth on the front of the document or
that any information we have incorporated by reference is correct
on any date subsequent to the date of the document incorporated by
reference, even though this prospectus and any accompanying
prospectus supplement is delivered or securities sold on a later
date. In this prospectus and any prospectus supplement,
unless otherwise indicated, the terms “Company,” “we,”
“our” and “us” refer to Zion Oil & Gas, Inc., a corporation
incorporated in the State of Delaware.
THIS PROSPECTUS MAY NOT BE USED TO OFFER AND SELL SECURITIES
UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.
SPECIAL NOTE REGARDING
FORWARD-LOOKING STATEMENTS
This prospectus and the documents included or incorporated by
reference in this prospectus contain statements concerning our
expectations, beliefs, plans, objectives, goals, strategies, future
events or performance and underlying assumptions and other
statements that are not historical facts. These statements are
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. You generally can
identify our forward-looking statements by the words “anticipate,”
“believe,” “budgeted,” “continue,” “could,” “estimate,” “expect,”
“forecast,” “goal,” “intend,” “may,” “objective,” “plan,”
“potential,” “predict,” “projection,” “scheduled,” “should,” “will”
or other similar words or the negative of these terms or other
comparable terminology and include, without limitation, statements
regarding:
|
● |
The
going concern qualification in our consolidated financial
statements; |
|
● |
our
liquidity and our ability to raise capital to finance our overall
exploration and development activities within our license
area; |
|
● |
our
ability to continue meeting the requisite continued listing
requirements by OTCQX; |
|
● |
the
outcome of the current SEC investigation against us; |
|
● |
Business interruptions from the COVID-19
pandemic; |
|
● |
our
ability to obtain new license areas to continue our petroleum
exploration program; |
|
● |
interruptions, increased consolidated financial
costs and other adverse impacts of the coronavirus pandemic on the
drilling and testing of our MJ#2 well and our capital raising
efforts; |
|
● |
our
ability to explore for and develop natural gas and oil resources
successfully and economically within our license area; |
|
● |
our
ability to maintain the exploration license rights to continue our
petroleum exploration program; |
|
● |
the
availability of equipment, such as seismic equipment, drilling
rigs, and production equipment as well as access to qualified
personnel; |
|
● |
the
impact of governmental regulations, permitting and other legal
requirements in Israel relating to onshore exploratory
drilling; |
|
● |
our
estimates of the time frame within which future exploratory
activities will be undertaken; |
|
● |
changes in our exploration plans and related
budgets; |
|
● |
the
quality of existing and future license areas with regard to, among
other things, the existence of reserves in economic
quantities; |
|
● |
anticipated trends in our business; |
|
● |
our
future results of operations; |
|
● |
our
capital expenditure program; |
|
● |
future market conditions in the oil and gas
industry |
|
● |
the
demand for oil and natural gas, both locally in Israel and
globally; and |
|
● |
The
impact of fluctuating oil and gas prices on our exploration
efforts |
More specifically, our forward-looking statements include, among
others, statements relating to our schedule, business plan,
targets, estimates or results of future drilling,
including the number, timing and results of wells, the timing and
risk involved in drilling follow-up wells, planned expenditures,
prospects budgeted and other future capital expenditures, risk
profile of oil and gas exploration, acquisition of seismic data
(including number, timing and size of projects), planned evaluation
of prospects, probability of prospects having oil and natural gas,
expected production or reserves, increases in reserves, acreage,
working capital requirements, hedging activities, the ability of
expected sources of liquidity to implement our business strategy,
future hiring, future exploration activity, production rates, all
and any other statements regarding future operations, financial
results, business plans and cash needs and other statements that
are not historical facts.
Such statements involve risks and uncertainties, including, but not
limited to, those relating to our dependence on our exploratory
drilling activities, the volatility of oil and natural gas prices,
the need to replace reserves depleted by production, operating
risks of oil and natural gas operations, our dependence on our key
personnel, factors that affect our ability to manage our growth and
achieve our business strategy, risks relating to our limited
operating history, technological changes, our significant capital
requirements, the potential impact of government regulations,
adverse regulatory determinations, litigation, competition, the
uncertainty of reserve information and future net revenue
estimates, property acquisition risks, industry partner issues,
availability of equipment, weather and other factors detailed
herein and in our other filings with the SEC.
We have based our forward-looking statements on our management’s
beliefs and assumptions based on information available to our
management at the time the statements are made. We caution you that
assumptions, beliefs, expectations, intentions and projections
about future events may and often do vary materially from actual
results. Therefore, we cannot assure you that actual results will
not differ materially from those expressed or implied by our
forward-looking statements.
Some of the factors that could cause actual results to differ from
those expressed or implied in forward-looking statements are
described under “Risk Factors” in this prospectus (page 11) and
described under “Risk Factors” and elsewhere in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2020 and
in our other periodic reports filed with the SEC. Should one or
more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual outcomes may vary
materially from those indicated. All subsequent written and oral
forward-looking statements attributable to us or persons acting on
our behalf are expressly qualified in their entirety by reference
to these risks and uncertainties. You should not place undue
reliance on our forward-looking statements. Each forward-looking
statement speaks only as of the date of the particular statement,
and we undertake no duty to update any forward-looking
statement.
SUMMARY
The following is only a summary, and does not contain all of the
information that you need to consider in making your investment
decision. We urge you to read this entire prospectus, including the
more detailed financial statements, notes to the financial
statements and other information incorporated by reference
into this prospectus under “Where You Can Find More Information”
and “Incorporation of Certain Information by Reference” from our
other filings with the SEC, as well as any prospectus supplement
applicable to an offering of the securities registered pursuant to
the registration statement of which this prospectus forms a part.
Investing in our securities involves risks. Therefore, please
carefully consider the information provided under the heading “Risk
Factors” beginning on page 11.
Our Company
Zion Oil and Gas, Inc., a Delaware corporation, is an oil and gas
exploration company with a history of 21 years of oil and gas
exploration in Israel. We were incorporated in Florida on April 6,
2000 and reincorporated in Delaware on July 9, 2003.
We completed our initial public offering in January 2007. Our
common stock, par value $0.01 per share (the “Common Stock”)
currently trades on the OTCQX under the symbol “ZNOG” and our
Common Stock warrant under the symbol “ZNOGW.”
The Company currently holds one active petroleum exploration
license onshore Israel, the New Megiddo License 428 (“NML 428”),
comprising approximately 99,000 acres. The NML 428 was awarded
on December 3, 2020 for a six-month term with the possibility of an
additional six-month extension. On April 29, 2021, Zion submitted a
request to the Ministry of Energy for a six-month extension to
December 2, 2021. On May 30, 2021, the Ministry of Energy approved
our request for extension to December 2, 2021. On November 29,
2021, the Ministry of Energy in Israel granted Zion Oil & Gas
an extension of the “New Megiddo”/428 License until August 1, 2022
for the purpose of completing the activities regarding its MJ-02
drilling and testing. The ML 428 lies onshore, south and west of
the Sea of Galilee and we continue our exploration focus here, as
it appears to possess the key geologic ingredients of an active
petroleum system with significant exploration potential.
The Megiddo Jezreel #1 (“MJ #1”) exploratory well was spud on June
5, 2017 and drilled to a total depth (“TD”) of 5,060 meters
(approximately 16,600 feet). Thereafter, the Company successfully
cased and cemented the well while awaiting the approval of the
testing protocol. The Ministry of Energy approved the well testing
protocol on April 29, 2018.
During the fourth quarter of 2018, the Company testing protocol was
concluded at the MJ #1 well. The test results confirmed that the MJ
#1 well did not contain hydrocarbons in commercial quantities in
the zones tested. As a result, in the year ended December 31, 2018,
the Company recorded a non-cash impairment charge to its unproved
oil and gas properties of $30,906,000. During the nine months ended
September 30, 2021, and 2020, respectively, the Company did not
record any post-impairment charges.
While the well was not commercially viable, Zion learned a great
deal from the drilling and testing of this well. We believe that
the drilling and testing of this well carried out the testing
objectives which would support further evaluation and potential
further exploration efforts within our License area. Zion believed
it was prudent and consistent with good industry practice to try
and answer some of these questions with a focused 3-D seismic
imaging shoot of approximately 72 square kilometers surrounding the
MJ#1 well. Zion completed all of the acquisition, processing and
interpretation of the 3-D data and incorporated its expanded
knowledge base into the drilling of our current MJ-02 exploratory
well.
On March 12, 2020, Zion entered into a Purchase and Sale Agreement
with Central European Drilling kft, a Hungarian corporation, to
purchase an onshore oil and gas drilling rig, drilling pipe,
related equipment and spare parts for a purchase price of $5.6
million in cash, subject to acceptance testing and potential
downward adjustment. We remitted to the Seller $250,000 on February
6, 2020 as earnest money towards the Purchase Price. The Closing
anticipated by the Agreement took place on March 12, 2020 by the
Seller’s execution and delivery of a Bill of Sale to us. On March
13, 2020, the Seller retained the earnest money deposit, and the
Company remitted $4,350,000 to the seller towards the purchase
price, and $1,000,000 (the “Holdback Amount”) was deposited in
escrow with American Stock Transfer and Trust Company LLC. On
January 6, 2021, Zion completed its acceptance testing of the I-35
drilling rig and the Holdback Amount was remitted to Central
European Drilling.
The MJ-02 drilling plan was approved by the Ministry of Energy on
July 29, 2020. On January 6, 2021, Zion officially spudded its
MJ-02 exploratory well. Zion plans to reach a total depth of
approximately 5,600 meters (~18,368 feet). On November 23, 2021
Zion announced that it reached a total depth of 5,531 meters
(~18,141 feet). A full set of detailed and comprehensive tests
including neutron-density, sonic, gamma, and resistivity logs,
paired with well testing, will commence during the coming weeks.
Based on these logs and analysis, additional zones of interest may
be identified and tested.
At present, we have no revenues or operating income. Our ability to
generate future revenues and operating cash flow will depend on the
successful exploration and exploitation of our current and any
future petroleum rights or the acquisition of oil and/or gas
producing properties, and the volume and timing of such production.
In addition, even if we are successful in producing oil and gas in
commercial quantities, our results will depend upon commodity
prices for oil and gas, as well as operating expenses including
taxes and royalties.
Our executive offices are located at 12655 North Central
Expressway, Suite 1000, Dallas, Texas 75243, and our telephone
number is (214) 221-4610. Our branch office’s address in Israel is
9 Halamish Street, North Industrial Park, Caesarea 3088900, and the
telephone number is +972-4-623-8500. Our website address is:
www.zionoil.com.
Exploration and Operation Efforts
Megiddo-Jezreel Petroleum License
The Company currently holds one active petroleum exploration
license onshore Israel, the New Megiddo License 428 (“NML 428”),
comprising approximately 99,000 acres. The NML 428 was awarded
on December 3, 2020 for a six-month term with the possibility of an
additional six-month extension. On April 29, 2021, Zion submitted a
request to the Ministry of Energy for a six-month extension to
December 2, 2021. On May 30, 2021, the Ministry of Energy approved
our request for extension to December 2, 2021. On November 29,
2021, the Ministry of Energy in Israel granted Zion Oil & Gas
an extension of the “New Megiddo”/428 License until August 1, 2022
for the purpose of completing the activities regarding its MJ-02
drilling and testing. The ML 428 lies onshore, south and west of
the Sea of Galilee, and we continue our exploration focus here as
it appears to possess the key geologic ingredients of an active
petroleum system with significant exploration potential.
The NML 428 lies onshore, south and west of the Sea of Galilee and
we continue our exploration focus here as it appears to possess the
key geologic ingredients of an active petroleum system with
significant exploration potential.
The previous Megiddo Jezreel #1 (“MJ #1”) exploratory well was
spudded on June 5, 2017 and drilled to a total depth (“TD”) of
5,060 meters (approximately 16,600 feet). Thereafter, the Company
successfully cased and cemented the well while awaiting the
approval of the testing protocol. The Ministry of Energy approved
the well testing protocol on April 29, 2018.
During the fourth quarter of 2018, the Company testing protocol was
concluded at the MJ #1 well. The test results confirmed that the MJ
#1 well did not contain hydrocarbons in commercial quantities in
the zones tested. As a result, in the year ended December 31, 2018,
the Company recorded a non-cash impairment charge to its unproved
oil and gas properties of $30,906,000. During the three and nine
months ended September 30, 2021, and 2020, respectively, the
Company did not record any post-impairment charges.
The MJ#1 well provided Zion with information Zion believes is
important for potential future exploration efforts within its
license area. As with many frontier wildcat wells, the MJ#1 also
left several questions unanswered.
While not meant to be an exhaustive list, a summary of what Zion
believes to be key information learned in the MJ#1 well is as
follows
|
1. |
The
MJ#1 encountered much higher subsurface temperatures at a depth
shallower than expected before drilling the well. In our opinion,
this is significant because reaching a minimum temperature
threshold is necessary for the generation of hydrocarbons from an
organic-rich source rock. |
|
|
|
|
2. |
The
known organic rich (potentially hydrocarbon bearing) Senonian age
source rocks that are typically present in this part of Israel were
not encountered as expected. Zion expected these source rocks to be
encountered at approximately 1,000 meters in the MJ#1
well. |
|
3. |
MJ#1
had natural fractures, permeability (the ability of fluid to move
through the rock) and porosity (pore space in rock) that allowed
the sustained flow of formation fluid in the shallower Jurassic and
lower Cretaceous age formations between approximately 1,200 and
1,800 meters. While no hydrocarbons were encountered, Zion believes
this fact is nonetheless significant because it provides important
information about possible reservoir pressures and the ability of
fluids to move within the formation and to the surface. |
|
4. |
MJ#1
encountered oil in the Triassic Mohilla formation which Zion
believes may indicate the presence of an active deep petroleum
system is in Zion’s license area. There was no natural permeability
or porosity in the Triassic Mohilla formation to allow formation
fluid to reach the surface naturally during testing, and thus the
MJ#1 was not producible or commercial. |
|
5. |
The
depths and thickness of the formations we encountered varied
greatly from pre-drill estimates. This required the MJ#1 to be
drilled to a much greater depth than previously expected. Zion has
tied these revised formation depths to seismic data which will
allow for more accurate interpretation and mapping in the
future. |
A summary of what Zion believes to be some key questions left to be
answered are:
|
1. |
Is
the missing shallow Senonian age source rock a result of regional
erosion, or is it missing because of a fault that cut the well-bore
and could be reasonably expected to be encountered in the vicinity
of the MJ#1 drill site? Zion believes this is an important question
to answer because if the Senonian source rocks do exist in this
area, the high temperatures encountered are sufficient to mature
these source rocks and generate oil. |
|
2. |
Do
the unusually high shallow subsurface temperatures extend
regionally beyond the MJ#1 well, which could allow for the
generation of hydrocarbons in the Senonian age source rock within
our license area? |
|
3. |
As a
consequence of seismic remapping, where does the MJ#1 well lie
relative to the potential traps at the Jurassic and Triassic
levels, and was the well location too low on the structures and
deeper than the potential hydrocarbons within those
traps? |
As a result of these unanswered questions and with the information
gained drilling the MJ#1 well, Zion believed it was prudent and
consistent with good industry practice to try and answer some of
these questions with a focused 3-D seismic imaging shoot of
approximately 72 square kilometers surrounding the MJ#1 well. Zion
has completed all of the acquisition, processing and interpretation
of the 3-D data and incorporated its expanded knowledge base into
the drilling of our current MJ-02 exploratory well (see further
details below).
The Geology team is continuing to work on a larger interpretation
of 3D areas, along with potential exploration locations located in
the western portion of the NML 428 area.

Map 1. Zion’s New Megiddo License 428 as of November 30,
2021.
As a result of these unanswered questions and with the information
gained drilling the MJ#1 well, Zion believed it was prudent and
consistent with good industry practice to try and answer some of
these questions with a focused 3-D seismic imaging shoot of
approximately 72 square kilometers surrounding the MJ#1 well. Zion
has completed all of the acquisition, processing and interpretation
of the 3-D data and has incorporated its expanded knowledge base
into the drilling of our current MJ-02 exploratory well (see
further details below). The Megiddo-Jezreel License 401 was awarded
on December 3, 2013 for a three-year primary term through December
2, 2016 with the possibility of additional one-year extensions up
to a maximum of seven years. The Megiddo-Jezreel License 401 lies
onshore, south and west of the Sea of Galilee, and we continue our
exploration focus here as it appears to possess the key geologic
ingredients of an active petroleum system with significant
exploration potential.
Current Exploration and Operation Efforts
On March 12, 2020, Zion entered into a Purchase and Sale Agreement
with Central European Drilling kft, a Hungarian corporation, to
purchase an onshore oil and gas drill rig, drilling pipe, related
equipment and spare parts for a purchase price of $5.6 million in
cash, subject to acceptance testing and potential downward
adjustment. We remitted to the Seller $250,000 on February 6, 2020
as earnest money towards the Purchase Price. The Closing
anticipated by the Agreement took place on March 12, 2020 by the
Seller’s execution and delivery of a Bill of Sale to us. On March
13, 2020, the Seller retained the earnest money deposit, and the
Company remitted $4,350,000 to the seller towards the purchase
price, and $1,000,000 (the “Holdback Amount”) was deposited in
escrow with American Stock Transfer and Trust Company LLC. On
January 6, 2021, Zion completed its acceptance testing of the I-35
drilling rig and the Holdback Amount was remitted to Central
European Drilling.
The Company currently holds one active petroleum exploration
license onshore Israel, the New Megiddo License 428 (“NML 428”),
comprising approximately 99,000 acres. This license
effectively replaced the Megiddo-Jezreel License 401 as it has the
same area and coordinates. The NML 428 was awarded on December 3,
2020 for a six-month term with the possibility of an additional
six-month extension. On April 29, 2021, Zion submitted a request to
the Ministry of Energy for a six-month extension to December 2,
2021. On May 30, 2021, the Ministry of Energy approved our request
for extension to December 2, 2021. On November 29, 2021, the
Ministry of Energy in Israel granted Zion Oil & Gas an
extension of the “New Megiddo”/428 License until August 1, 2022 for
the purpose of completing the activities regarding its MJ-02
drilling and testing. The ML 428 lies onshore, south and west of
the Sea of Galilee, and we continue our exploration focus here as
it appears to possess the key geologic ingredients of an active
petroleum system with significant exploration potential.
Onshore Licensing, Oil and Gas Exploration and Environmental
Guidelines
The Company is engaged in oil and gas exploration and production
and may become subject to certain liabilities as they relate to
environmental cleanup of well sites or other environmental
restoration procedures and other obligations as they relate to the
drilling of oil and gas wells or the operation thereof. Various
guidelines have been published in Israel by the State of Israel’s
Petroleum Commissioner, the Energy Ministry, and the Environmental
Ministry in recent years as it pertains to oil and gas activities.
Mention of these guidelines was included in previous Zion Oil &
Gas filings.
We acknowledge that these new regulations are likely to increase
the expenditures associated with obtaining new exploration rights
and drilling new wells. The Company expects that additional
financial burdens could occur as a result of the Ministry requiring
cash reserves that could otherwise be used for operational
purposes.
Financing Activities
We need to raise significant funds to finance the continued
exploration efforts and maintain orderly operations. To date, we
have funded our operations through the issuance of our securities
and convertible debt. We will need to continue to raise funds
through the issuance of equity and/or debt securities (or
securities convertible into or exchangeable for equity securities).
No assurance can be provided that we will be successful in raising
the needed capital on terms favorable to us (or at all).
The Dividend Reinvestment and Stock Purchase Plan
On March 27, 2014, the Company launched its Dividend Reinvestment
and Stock Purchase Plan (the “DSPP”) pursuant to which stockholders
and interested investors could purchase shares of the Company’s
Common Stock as well as units of the Company’s securities directly
from the Company. The terms of the DSPP are described in the
Prospectus Supplement originally filed on March 31, 2014 (the
“Original Prospectus Supplement”) with the Securities and Exchange
Commission (“SEC”) under the Company’s effective registration
Statement on Form S-3, as thereafter amended.
On February 23, 2017, the Company filed a Form S-3 with the SEC
(Registration No. 333-216191) as a replacement for the Form S-3
(Registration No. 333-193336), in which the three (3) year period
was ending March 31, 2017, along with the base Prospectus and
Supplemental Prospectus. The Form S-3, as amended, and the new base
Prospectus became effective on March 10, 2017, along with the
Prospectus Supplement that was filed and became effective on March
10, 2017. The Prospectus Supplement under Registration No.
333-216191 describes the terms of the DSPP and replaces the prior
Prospectus Supplement, as amended, under the prior Registration No.
333-193336.
On November 27, 2019, the Company filed a Form S-3 to Form S-1
conversion with the SEC (Registration No. 333-235299) as a
replacement for the Form S-3 (Registration No. 333-216191), along
with the base Prospectus and Supplemental Prospectus. The Form S-1,
as amended, and the new base Prospectus became effective on
December 9, 2019, along with the Prospectus Supplement that was
filed and became effective on December 9, 2019. The Prospectus
Supplement under Registration No. 333-235299 described the terms of
the DSPP and replaced the prior Prospectus Supplement, as amended,
under the prior Registration No. 333-216191.
For the nine months ended September 30, 2021, approximately
$18,157,000 was raised and from October 1, 2021 to November 10,
2021 approximately $4,378,000 was raised under the DSPP
program.
The Warrants transactions since September 30, 2021 are shown in the
table below:
Warrants |
|
Exercise Price |
|
|
Warrant Termination Date |
|
Outstanding Balance, 12/31/18 |
|
|
Warrants Issued |
|
|
Warrants Exercised |
|
|
Warrants Expired |
|
|
Outstanding Balance, 9/30/19 |
|
ZNWAA |
|
$ |
2.00 |
|
|
01/31/2023 |
|
|
1,498,804 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
1,498,804 |
|
ZNWAD |
|
$ |
1.00 |
|
|
05/02/2023 |
|
|
243,853 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
243,853 |
|
ZNWAE |
|
$ |
1.00 |
|
|
05/02/2023 |
|
|
2,144,099 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
2,144,099 |
|
ZNWAF |
|
$ |
1.00 |
|
|
08/14/2023 |
|
|
359,435 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
359,435 |
|
ZNWAG |
|
$ |
1.00 |
|
|
01/08/2023 |
|
|
240,068 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
240,068 |
|
ZNWAH |
|
$ |
5.00 |
|
|
04/19/2023 |
|
|
372,400 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
372,400 |
|
ZNWAI |
|
$ |
3.00 |
|
|
06/29/2023 |
|
|
640,730 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
640,730 |
|
ZNWAJ |
|
$ |
1.00 |
|
|
10/29/2023 |
|
|
545,900 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
545,900 |
|
ZNWAK |
|
$ |
0.01 |
|
|
02/25/2023 |
|
|
437,875 |
|
|
|
0 |
|
|
|
(6,220 |
) |
|
|
0 |
|
|
|
431,655 |
|
ZNWAL |
|
$ |
2.00 |
|
|
08/26/2023 |
|
|
517,875 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
517,875 |
|
ZNWAM |
|
$ |
1.00 |
|
|
07/15/2022 |
|
|
|
|
|
|
4,376,000 |
|
|
|
0 |
|
|
|
0 |
|
|
|
4,376,000 |
|
ZNWAN |
|
$ |
1.00 |
|
|
07/15/2022 |
|
|
|
|
|
|
267,725 |
|
|
|
(100 |
) |
|
|
0 |
|
|
|
267,685 |
|
ZNWAO |
|
$ |
0.25 |
|
|
06/12/2023 |
|
|
|
|
|
|
190,480 |
|
|
|
(15,200 |
) |
|
|
0 |
|
|
|
175,280 |
|
ZNWAP |
|
$ |
0.25 |
|
|
04/03/2022 |
|
|
|
|
|
|
1,639,916 |
|
|
|
(1,200,000 |
) |
|
|
0 |
|
|
|
439,916 |
|
ZNWAR |
|
$ |
0.25 |
|
|
06/23/2022 |
|
|
|
|
|
|
1,020,000 |
|
|
|
|
|
|
|
0 |
|
|
|
1,020,000 |
|
Outstanding warrants |
|
|
|
|
|
|
|
|
7,001,039 |
|
|
|
7,494,181 |
|
|
|
(1,221,520 |
) |
|
|
0 |
|
|
|
13,273,700 |
|
According to the warrant table, the Company could potentially raise
up to approximately $16,408,000, if all outstanding warrants were
exercised by its holders.
The Securities We May Offer
We may offer shares of our common stock, various series of debt
securities and warrants to purchase any of such securities, either
individually or in units, with a total value of up to approximately
$401,665,888 from time to time under this prospectus at prices and
on terms to be determined by market conditions at the time of
offering. This prospectus provides you with a general description
of the securities we may offer. Each time we offer a type or
series of securities, we will provide a prospectus supplement that
will describe the specific amounts, prices and other important
terms of the securities, including, to the extent applicable:
|
· |
aggregate principal amount or
aggregate offering price; |
|
· |
maturity, if applicable; |
|
· |
original issue discount, if any; |
|
· |
rates
and times of payment of interest, if any; |
|
· |
redemption, conversion, exchange or sinking fund
terms, if any; |
|
· |
conversion or exchange prices or rates, if any, and, if applicable,
any provisions for changes to or adjustments in the conversion or
exchange prices or rates and in the securities or other property
receivable upon conversion or exchange;
|
|
· |
restrictive covenants, if any; |
|
· |
voting or other rights, if any; and |
|
· |
important federal income tax
considerations. |
The prospectus supplement also may add, update or change
information contained in this prospectus or in documents we have
incorporated by reference into this prospectus. However, no
prospectus supplement will offer a security that is not registered
and described in this prospectus at the time of the effectiveness
of the registration statement of which this prospectus is a
part.
We may sell the securities directly to or through underwriters,
dealers or agents. We, and our underwriters or agents,
reserve the right to accept or reject all or part of any proposed
purchase of securities. Currently, we sell securities
directly through our Dividend Reinvestment and Common Stock
Purchase Plan. If we do offer securities through underwriters or
agents, we will include in the applicable prospectus
supplement:
|
· |
the names of those underwriters
or agents; |
|
· |
applicable fees, discounts and
commissions to be paid to them; |
|
· |
details regarding over-allotment
options, if any; and |
|
· |
the net proceeds to
us. |
The following is a summary of the securities we may offer with this
prospectus.
Common Stock. We currently have authorized
800,000,000 shares of common stock, par value $0.01 per share. We
may offer shares of our common stock either alone or underlying
other registered securities convertible into or exercisable for our
common stock from time to time. Holders of our common stock are
entitled to one vote per share for the election of directors and on
all other matters that require stockholder approval. In
the event of our liquidation, dissolution or winding up, holders of
our common stock are entitled to share ratably in the assets
remaining after payment of liabilities. Currently, we do not
pay any dividends. Our common stock does not carry any preemptive
rights enabling a holder to subscribe for, or receive shares of,
any class of our common stock or any other securities convertible
into shares of any class of our common stock, or any redemption
rights.
Debt Securities. We may offer debt securities
from time to time, in one or more series, as either senior or
subordinated debt or as senior or subordinated convertible
debt. The senior debt securities will rank equally with any
other unsubordinated debt that we may have and may be secured or
unsecured. The subordinated debt securities will be
subordinate and junior in right of payment, to the extent and in
the manner described in the instrument governing the debt, to all
or some portion of our indebtedness. Any convertible debt
securities that we issue will be convertible into or exchangeable
for our common stock or other securities of ours. Conversion
may be mandatory or at your option and would be at prescribed
conversion rates.
Any debt securities will be issued under one or more documents
called indentures, which are contracts between us and a trustee for
the holders of the debt securities. In this prospectus, we
have summarized certain general and standard features of the debt
securities we may issue. We urge you, however, to read the
prospectus supplements related to the series of debt securities
being offered, as well as the complete indentures that contain the
terms of the debt securities. We will file as
exhibits to the registration statement of which this
prospectus is a part, or will incorporate by reference into such
registration statement from a Current Report on Form 8-K that we
file with the SEC, the forms of indentures and any supplemental
indentures and the forms of debt securities containing the terms of
debt securities we are offering before the issuance of any series
of debt pursuant to the Registration Statement of which this
prospectus forms a part.
Warrants. We may offer warrants for the purchase of
our common stock, and/or debt securities in one or more series,
from time to time. We may issue warrants independently or
together with common stock, and/or debt securities and the warrants
may be attached to or separate from those securities.
The warrants will be evidenced by warrant certificates issued under
one or more warrant agreements, which are contracts between us and
an agent for the holders of the warrants. In this prospectus,
we have summarized certain general and standard features of the
warrants. We urge you, however, to read the prospectus
supplements related to the series of warrants being offered, as
well as the warrant agreements and warrant certificates that
contain the terms of the warrants. We will file as exhibits
to the registration statement of which this prospectus is
a part, or will incorporate by reference into such
registration statement from a Current Report on Form 8-K that we
file with the SEC, the form of warrant agreements and form of
warrant certificates relating to warrants for the purchase of
common stock and debt securities we are offering before the
issuance of any such warrants pursuant to the Registration
Statement of which this prospectus forms a part.
Units. We may offer units consisting of common
stock, debt securities and/or warrants to purchase any of such
securities in one or more series. In this prospectus, we have
summarized certain general and standard features of the units. We
urge you, however, to read the prospectus supplements related to
the series of units being offered, as well as the unit agreements
that contain the terms of the units. We will file as exhibits to
the registration statement of which this prospectus is a part, or
will incorporate by reference from a Current Report on Form 8-K
that we file with the SEC, the form of unit agreement and any
supplemental agreements that describe the terms of the series of
units we are offering before the issuance of the related series of
units pursuant to the Registration Statement of which this
prospectus forms a part.
We will evidence each series of units by unit certificates that we
will issue under a separate agreement. We will enter into the unit
agreements with a unit agent. Each unit agent will be a bank or
trust company that we select. We will indicate the name and address
of the unit agent in the applicable prospectus supplement relating
to a particular series of units.
THIS PROSPECTUS MAY NOT BE USED TO OFFER OR SELL ANY SECURITIES
UNLESS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.
RISK FACTORS
Before making an investment decision, you should carefully consider
the risks described under “Risks Related to our Business” below and
in the applicable prospectus supplement, together with all of the
other information appearing in this prospectus or incorporated by
reference into this prospectus and any applicable prospectus
supplement, in light of your particular investment objectives and
financial circumstances. Our business, financial condition or
results of operations could be materially adversely affected by any
of these risks. The trading price of our securities could decline
due to any of these risk factors, and you may lose all or any part
of your investment.
Risks Related to our Business
We are an oil and gas exploration company with no current source
of revenue. Our ability to continue in business depends upon our
continued ability to obtain significant financing from external
sources and the success of our exploration efforts, none of which
can be assured.
During the quarter ended September 30, 2021, there were no material
changes to the risk factors previously reported in our Annual
Report on Form 10-K for the year ended December 31, 2020.
USE OF PROCEEDS
Unless otherwise indicated in the prospectus supplement applicable
to an offering, we intend to use any net proceeds from the sale of
our securities to fund our operations and for other general
corporate purposes, such as additions to working capital, expansion
of our drilling and other exploration efforts and further our
efforts to possibly acquire a majority working interest in a
deep-drilling capacity onshore drilling rig. We have not determined
the amount of net proceeds to be used specifically for the
foregoing purposes.
When we offer a particular series of securities, we will describe
the intended use of the net proceeds from that offering in a
prospectus supplement. The actual amount of net proceeds we spend
on a particular use will depend on many factors, including, our
future capital expenditures, the amount of cash required by our
operations, and our future revenue growth, if any. Therefore, we
will retain broad discretion in the use of the net proceeds.
DESCRIPTION OF CAPITAL
STOCK
Our authorized share capital consists of 800,000,000 shares of
common stock, par value $0.01 per share. As of September 30, 2021,
there were 304,260,077 common shares outstanding. All outstanding
shares of common stock are fully paid and non-assessable.
The following description of our common stock, together with any
additional information we include in any applicable prospectus
supplement, summarizes the material terms and provisions of our
common stock that we may offer under this prospectus. While the
terms we have summarized below will apply generally to any future
common stock that we may offer, we will describe the particular
terms of any class or series of these securities in more detail in
the applicable prospectus supplement. For the complete terms
of our common stock, please refer to our certificate of
incorporation and our bylaws that are incorporated by reference
into the registration statement of which this prospectus is a part
or may be incorporated by reference in this prospectus or any
applicable prospectus supplement. The summary below and that
contained in any applicable prospectus supplement are qualified in
their entirety by reference to our certificate of incorporation and
bylaws.
Common Stock
Voting. Holders of shares of common stock are entitled to
one vote for each share on all matters to be voted on by the
stockholders. They are not entitled to cumulative voting
rights.
Dividends and Other Distributions. Holders of our common
stock are entitled to share in an equal amount per share in any
dividends declared by our board of directors on the common stock
and paid out of legally available assets.
Distributions on Dissolution. In the event of our
liquidation, dissolution or winding up, holders of our common stock
are entitled to share ratably in the assets remaining after payment
of liabilities.
Other Rights. Our common stock does not carry any preemptive
rights enabling a holder to subscribe for, or receive shares of,
any class of our common stock or any other securities convertible
into shares of any class of our common stock. There are no
conversion or redemption rights or sinking funds provided for our
stockholders.
Certificate of Incorporation and Bylaws Provisions
The following summary describes provisions of our certificate of
incorporation and bylaws. They may have the effect of discouraging
a tender offer, proxy contest or other takeover attempt that is
opposed by our board of directors. These provisions include:
|
· |
restrictions on the rights of
shareholders to remove directors; |
|
|
|
|
· |
limitations against shareholders calling a Special Meeting of
shareholders or acting by unanimous written consent in lieu of a
meeting;
|
|
|
|
|
· |
requirements for advance notice of actions proposed by shareholders
for consideration at meetings of the shareholders; and
|
|
|
|
|
· |
restrictions on business combination transactions
with “related persons.” |
Classified board of directors and removal
Our certificate of incorporation provides that the board of
directors shall be divided into three classes, designated Class I,
Class II and Class III, with the classes to be as nearly equal in
number as possible. The term of office of each class expires at the
third Annual Meeting of Shareholders for the election of directors
following the election of such class (except for the initial
classes). Directors may be removed only for cause and only upon the
affirmative vote of holders of at least 66 2/3% of our voting stock
at a Special Meeting of Shareholders called expressly for that
purpose. The classification of directors could have the effect of
making it more difficult for shareholders to change the composition
of the board of directors. At least two Annual Meetings of
Shareholders, instead of one, are generally required to effect a
change in a majority of the board of directors.
The classification provisions could also have the effect of
discouraging a third party from initiating a proxy contest, making
a tender offer or otherwise attempting to obtain control of our
company, even though such an attempt might be beneficial to us and
our shareholders. The classification of the board of directors
could thus increase the likelihood that incumbent directors will
retain their positions. In addition, because the classification
provisions may discourage accumulations of large blocks of stock by
purchasers whose objective is to take control of our company and
remove a majority of the board of directors, the classification of
the board of directors could tend to reduce the likelihood of
fluctuations in the market price of the common stock that might
result from accumulations of large blocks. Accordingly,
shareholders could be deprived of opportunities to sell their
shares of common stock at a higher market price than might
otherwise be the case.
Shareholder action by written consent and special
meetings
Our bylaws provide that shareholder action can be taken only at an
Annual or Special Meeting of shareholders and may not be taken by
written consent in lieu of a meeting once our number of
shareholders exceeded sixty, which occurred in the first quarter of
2003. Special Meetings of shareholders can be called only upon a
resolution adopted by the board of directors. Moreover, the
business permitted to be conducted at any Special Meeting of
shareholders is limited to the business brought before the meeting
under the Notice of Meeting given by us. These provisions may have
the effect of delaying consideration of a shareholder proposal
until the next Annual Meeting. These provisions would also prevent
the holders of a majority of our voting stock from unilaterally
using the written consent or Special Meeting procedure to take
shareholder action.
Advance notice provisions for shareholder nominations and
shareholder proposals
Our bylaws establish an advance notice procedure for
shareholders to make nominations of candidates for election as
directors or bring other business before a meeting of shareholders.
The shareholder notice procedure provides that only persons who are
nominated by, or at the direction of, the board of directors, or by
a shareholder who has given timely written notice containing
specified information to our secretary prior to the meeting at
which directors are to be elected, will be eligible for election as
our directors. The shareholder notice procedure also provides that
at a meeting of the shareholders only such business may be
conducted as has been brought before the meeting by, or at the
direction of, the chairman of the board of directors, or in the
absence of the chairman of the board, the chief executive officer,
the president, or by a shareholder who has given timely written
notice containing specified information to our secretary of such
shareholder’s intention to bring such business before such
meeting.
Although our bylaws do not give the board of directors any power to
approve or disapprove shareholder nominations for the election of
directors or proposals for action, they may have the effect of
precluding a contest for the election of directors or the
consideration of shareholder proposals if the proper procedures are
not followed, and of discouraging or deterring a third party from
conducting a solicitation of proxies to elect its own slate of
directors or to approve its own proposal, without regard to whether
consideration of such nominees or proposals might be harmful or
beneficial to Zion and our shareholders.
Business combination provision
Our certificate of incorporation contains a provision for approval
of specified business combination transactions involving any
person, entity or group that beneficially owns at least 10% of our
aggregate voting stock. Such person, entity or group is sometimes
referred to as a “related person”. This provision requires the
affirmative vote of the holders of not less than 66 2/3% of our
voting stock to approve specified transactions between a related
person and Zion, including:
|
· |
any merger or
consolidation; |
|
|
|
|
· |
any sale, lease, exchange, mortgage, pledge, transfer or other
disposition of our assets having a fair market value of more than
10% of our total assets, or assets representing more than 10% of
our cash flow or earning power, or 10% of stockholders’ equity,
which is referred to as a “substantial part”;
|
|
|
|
|
· |
any sale, lease, exchange, mortgage, pledge, transfer or other
disposition to or with us of all or a substantial part of the
assets of a related person;
|
|
|
|
|
· |
any reclassification of securities, recapitalization, or any other
transaction involving us that would have the effect of increasing
the voting power of a related person;
|
|
|
|
|
· |
the adoption of a plan or proposal for our liquidation or
dissolution proposed by or on behalf of a related person; and
|
|
|
|
|
· |
the entering into of any agreement, contract or other arrangement
providing for any of the transactions described above.
|
This voting requirement will not apply to certain transactions,
including any transaction approved by a majority vote of the
directors (called “Disinterested Directors”) who are not affiliated
or associated with the related person described above, provided
that there are at least three Disinterested Directors. This
provision could have the effect of delaying or preventing a change
in control of Zion in a transaction or series of transactions.
Liability of directors and indemnification
Our certificate of incorporation provides that a director will not
be personally liable to us or our shareholders for breach of
fiduciary duty as a director, except to the extent that such
exemption or limitation of liability is not permitted under
Delaware General Corporation Law. Any amendment or repeal of such
provisions may not adversely affect any right or protection of a
director existing under our certificate of incorporation for any
act or omission occurring prior to such amendment or repeal.
Our certificate of incorporation and bylaws provide that each
person who at any time serves or served as one of our directors or
officers, or any person who, while one of our directors or
officers, is or was serving at our request as a director or officer
of another corporation, partnership, joint venture, trust or other
enterprise, is entitled to indemnification and the advancement of
expenses from us, to the fullest extent permitted by applicable
Delaware law. However, as provided under applicable Delaware
General Corporation Law, this indemnification will only be provided
if the indemnitee acted in good faith and in a manner he or she
reasonably believed to be in, or not opposed to, the best interests
of our company.
Amendments
Our certificate of incorporation provides that we reserve the right
to amend, alter, change, or repeal any provision contained in our
certificate of incorporation, and all rights conferred to
shareholders are granted subject to such reservation. The
affirmative vote of holders of not less than 80% of our voting
stock, voting together as a single class, is required to alter,
amend, adopt any provision inconsistent with, or to repeal certain
specified provisions of our certificate of incorporation. However,
the 80% vote described in the prior sentence is not required for
any alteration, amendment, adoption of inconsistent provision or
repeal of the “business combination” provision discussed under the
“Business combination provision” paragraph above which is
recommended to the shareholders by two-thirds of our Disinterested
Directors, and such alteration, amendment, adoption of inconsistent
provision or repeal shall require the vote, if any, required under
the applicable provisions of the Delaware General Corporation Law,
our certificate of incorporation and our bylaws. In addition, our
bylaws provide that shareholders may only adopt, amend or repeal
our bylaws by the affirmative vote of holders of not less than
66-2/3% of our voting stock, voting together as a single class. Our
bylaws may also be amended by the affirmative vote of two-thirds of
our board of directors.
Listing Symbols on the securities market
Our common stock is quoted on the OTCQX under the symbol “ZNOG” The
sale price of our common stock on the OTCQX on November 29, 2021
was $0.266. We also have one common stock purchase warrant quoted
on the OTCQX under the symbol “ZNOGW” since March 31, 2014. The
applicable prospectus supplement will contain information, where
applicable, as to any other listing on the OTCQX or any securities
market or other exchange of the securities, if any, covered by the
prospectus supplement.
Transfer Agent and Registrar
The transfer agent and registrar for our common stock is American
Stock Transfer & Trust Company, LLC, Brooklyn, New York.
DESCRIPTION OF DEBT
SECURITIES
The following description, together with the additional information
we include in any applicable prospectus supplements, summarizes the
general terms and provisions of the debt securities that we may
offer under this prospectus. While the terms we have
summarized below will generally apply to any future debt securities
we may offer under this prospectus, we will describe the particular
terms of any debt securities that we may offer in more detail in
the applicable prospectus supplement. The terms of any debt
securities we offer under a prospectus supplement may differ from
the terms we describe below. However, no prospectus
supplement shall fundamentally change the terms that are set forth
in this prospectus or offer a security that is not registered and
described in this prospectus at the time of its
effectiveness. As of the date of this prospectus, we have no
outstanding registered debt securities.
We may issue one or more series of notes under indentures, which we
will enter into with the trustee to be named therein. If we
issue debt securities, we will file these documents as exhibits to
the registration statement of which this prospectus is a part, or
incorporate them by reference from a Current Report on Form 8-K
that we file with the SEC. We use the term “indentures” to
refer to any and all indentures that we may enter into with respect
to debt securities issued and sold pursuant to this Registration
Statement.
The indentures will be qualified under the Trust Indenture Act of
1939. We use the term “debenture trustee” to refer to either
the senior trustee or the subordinated trustee, as applicable.
The following summaries of material provisions of the debt
securities are subject to, and qualified in their entirety by
reference to, all the provisions of the indenture applicable to a
particular series of debt securities. We urge you to read the
applicable prospectus supplements related to the debt securities
that we sell under this prospectus, as well as the complete
indentures that contain the terms of the debt securities.
Except as we may otherwise indicate, the terms of the senior and
the subordinated indentures are identical.
General
The indentures may limit the aggregate principal amount of the debt
securities which we may issue and will provide that we may issue
the debt securities from time to time in one or more series. The
indentures may or may not limit the amount of our other
indebtedness or the debt securities which we may issue. The
particular terms of each series of debt securities will be
described in a prospectus supplement relating to such series,
including any pricing supplement. The prospectus
supplement will set forth:
|
· |
the
principal amount being offered, and, if a series, the total amount
authorized and the total amount outstanding; |
|
· |
any limit on the amount that may
be issued; |
|
· |
whether or not we will issue the series of debt securities in
global form and, if so, the terms and who the depositary will
be;
|
|
· |
whether and under what circumstances, if any, we will pay
additional amounts on any debt securities held by a person who is
not a United States person for tax purposes, and whether we can
redeem the debt securities if we have to pay such additional
amounts;
|
|
· |
the annual interest rate, which may be fixed or variable, or the
method for determining the rate, the date interest will begin to
accrue, the dates interest will be payable and the regular record
dates for interest payment dates or the method for determining such
dates;
|
|
· |
whether or not the debt securities will be
secured or unsecured, and the terms of any secured
debt; |
|
· |
the terms of the subordination of
any series of subordinated debt; |
|
· |
the place where payments will be
payable; |
|
· |
restrictions on transfer, sale or
other assignment, if any; |
|
· |
our
right, if any, to defer payment of interest and the maximum length
of any such deferral period; |
|
· |
the date, if any, after which, the conditions upon which, and the
price at which we may, at our option, redeem the series of debt
securities pursuant to any optional or provisional redemption
provisions, and any other applicable terms of those redemption
provisions;
|
|
· |
the date, if any, on which, and the price at which we are
obligated, pursuant to any mandatory sinking fund or analogous fund
provisions or otherwise, to redeem, or at the holder’s option to
purchase, the series of debt securities and the currency or
currency unit in which the debt securities are payable;
|
|
· |
whether the indenture will restrict our ability
to: |
|
· |
incur additional
indebtedness; |
|
· |
issue additional
securities; |
|
· |
pay dividends and make distributions in respect of our capital
stock;
|
|
· |
redeem capital stock; |
|
· |
place
restrictions on our subsidiaries’ ability to pay dividends, make
distributions or transfer assets; |
|
· |
make investments or other
restricted payments; |
|
· |
sell or otherwise dispose of
assets; |
|
· |
enter into sale-leaseback
transactions; |
|
· |
engage in transactions with
stockholders and affiliates; |
|
· |
issue or sell stock of our
subsidiaries; or |
|
· |
effect a consolidation or
merger; |
|
· |
whether the indenture will require us to maintain any interest
coverage, fixed charge, cash flow-based, asset-based or other
financial ratios;
|
|
· |
a discussion of any material or special United States federal
income tax considerations applicable to the debt securities;
|
|
· |
information describing any
book-entry features; |
|
· |
provisions for a sinking fund purchase or other
analogous fund, if any; |
|
· |
whether the debt securities are to be offered at a price such that
they will be deemed to be offered at an “original issue discount”
as defined in paragraph (a) of Section 1273 of the Internal Revenue
Code;
|
|
· |
the procedures for any auction
and remarketing, if any; |
|
· |
the denominations in which we will issue the series of debt
securities, if other than denominations of $1,000 and any integral
multiple thereof;
|
|
· |
if
other than dollars, the currency in which the series of debt
securities will be denominated; and |
|
· |
any other specific terms, preferences, rights or limitations of, or
restrictions on, the debt securities, including any events of
default that are in addition to those described in this prospectus
or any covenants provided with respect to the debt securities that
are in addition to those described above, and any terms which may
be required by us or advisable under applicable laws or regulations
or advisable in connection with the marketing of the debt
securities.
|
Conversion or Exchange Rights
We will set forth in the prospectus supplement the terms on which a
series of debt securities may be convertible into or exchangeable
for common stock or other securities of ours or a third party,
including the conversion or exchange rate, as applicable, or how it
will be calculated, and the applicable conversion or exchange
period. We will include provisions as to whether conversion
or exchange is mandatory, at the option of the holder or at our
option. We may include provisions pursuant to which the
number of our securities or the securities of a third party that
the holders of the series of debt securities receive upon
conversion or exchange would, under the circumstances
described in those provisions, be subject to adjustment, or
pursuant to which those holders would, under those circumstances,
receive other property upon conversion or exchange, for example in
the event of our merger or consolidation with another entity.
Consolidation, Merger or Sale
The description of the debt securities in the prospectus supplement
or the indentures may provide that we may not consolidate or
amalgamate with or merge into any person or convey, transfer or
lease our properties or assets as an entirety or substantially as
an entirety to any person, and we may not permit any person to
consolidate or amalgamate with or merge into us, or convey,
transfer or lease its properties and assets as an entirety or
substantially as an entirety to us, unless:
|
· |
immediately after giving effect to the transaction, no event of
default, and no event which after notice or lapse of time or both
would become an event of default, will have occurred and be
continuing; and
|
|
· |
certain other conditions are
met. |
If the debt securities are convertible for our other securities,
the person with whom we consolidate or merge or to whom we sell all
of our property must make provisions for the conversion of the debt
securities into securities that the holders of the debt securities
would have received if they had converted the debt securities
before the consolidation, merger or sale.
Events of Default under the Indenture
Each of the following constitute reasonably standard events of
default that may be included in any finalized indenture or
prospectus supplement as constituting an event of default with
respect to any series of debt securities that we may issue:
|
· |
if we fail to pay interest when due and payable and our failure
continues for 30 days and the time for payment has not been
extended or deferred;
|
|
· |
if we fail to pay the principal, sinking fund payment or premium,
if any, when due and payable and the time for payment has not been
extended or delayed;
|
|
· |
if we fail to observe or perform any other covenant contained in
the debt securities or the indentures, other than a covenant
specifically relating to another series of debt securities, and our
failure continues for 90 days after we receive notice from the
debenture trustee or holders of at least 25% in aggregate principal
amount of the outstanding debt securities of the applicable
series;
|
|
· |
if specified events of
bankruptcy, insolvency or reorganization occur; and |
|
· |
any other event of default provided in or pursuant to the
applicable indenture or prospectus supplement with respect to the
debt securities of that series.
|
If an event of default with respect to debt securities of any
series occurs and is continuing, other than an event of default in
the event of bankruptcy, insolvency or reorganization, the
debenture trustee or the holders of at least 25% in aggregate
principal amount of the outstanding debt securities of that series,
by notice to us in writing, and to the debenture trustee if notice
is given by such holders, may declare the unpaid principal of,
premium, if any, and accrued interest, if any, due and payable
immediately. If an event of default due to bankruptcy,
insolvency or reorganization occurs with respect to us, the
principal amount of and accrued interest, if any, of each issue of
debt securities then outstanding shall be due and payable without
any notice or other action on the part of the debenture trustee or
any holder.
The
holders of a majority in principal amount of the outstanding debt
securities of an affected series may waive any default or event of
default with respect to the series and its consequences, except
defaults or events of default regarding payment of principal,
premium, if any, or interest, unless we have cured the default or
event of default in accordance with the indenture.
Subject
to the terms of the indentures, if an event of default under an
indenture shall occur and be continuing, the debenture trustee will
be under no obligation to exercise any of its rights or powers
under such indenture at the request or direction of any of the
holders of the applicable series of debt securities, unless such
holders have offered the debenture trustee reasonable
indemnity. The holders of a majority in principal amount of
the outstanding debt securities of any series will have the right
to direct the time, method and place of conducting any proceeding
for any remedy available to the debenture trustee, or exercising
any trust or power conferred on the debenture trustee, with respect
to the debt securities of that series, provided that:
|
● |
the
direction so given by the holder is not in conflict with any law or
the applicable indenture; and |
|
● |
subject
to its duties under the Trust Indenture Act of 1939, the debenture
trustee need not take any action that might involve it in personal
liability or might be unduly prejudicial to the holders not
involved in the proceeding. |
A
holder of the debt securities of any series will only have the
right to institute a proceeding under the indentures or to appoint
a receiver or trustee, or to seek other remedies if:
|
● |
the
holder has given written notice to the debenture trustee of a
continuing event of default with respect to that
series; |
|
● |
the
holders of at least 25% in aggregate principal amount of the
outstanding debt securities of that series have made written
request, and such holders have offered reasonable indemnity to the
debenture trustee to institute the proceeding as trustee;
and |
|
● |
the
debenture trustee does not institute the proceeding, and does not
receive from the holders of a majority in aggregate principal
amount of the outstanding debt securities of that series other
conflicting directions within 90 days after the notice, request and
offer. |
These
limitations do not apply to a suit instituted by a holder of debt
securities if we default in the payment of the principal, premium,
if any, or interest on, the debt securities.
We
will periodically file statements with the debenture trustee
regarding our compliance with specified covenants in the
indentures.
Modification
of Indenture; Waiver
We
and the debenture trustee may change an indenture without the
consent of any holders with respect to specific matters,
including:
|
● |
to
fix any ambiguity, defect or inconsistency in the
indenture; |
|
● |
to
comply with the provisions described above under “Consolidation,
Merger or Sale”; |
|
● |
to
comply with any requirements of the SEC in connection with the
qualification of any indenture under the Trust Indenture Act of
1939; |
|
● |
to
evidence and provide for the acceptance of appointment by a
successor trustee; |
|
● |
to
provide for uncertificated debt securities and to make all
appropriate changes for such purpose; |
|
● |
to
add to, delete from, or revise the conditions, limitations and
restrictions on the authorized amount, terms or purposes of
issuance, authorization and delivery of debt securities or any
series, as set forth in the indenture; |
|
● |
to
provide for the issuance of and establish the form and terms and
conditions of the debt securities of any series as provided under
“General,” to establish the form of any certifications required to
be furnished pursuant to the terms of the indenture or any series
of debt securities, or to add to the rights of the holders of any
series of debt securities; |
|
● |
to
add to our covenants such new covenants, restrictions, conditions
or provisions for the protection of the holders, to make the
occurrence, or the occurrence and the continuance, of a default in
any such additional covenants, restrictions, conditions or
provisions an event of default, or to surrender any of our rights
or powers under the indenture; or |
|
● |
to
change anything that does not materially adversely affect the
interests of any holder of debt securities of any
series. |
In
addition, under the indentures, the rights of holders of a series
of debt securities may be changed by us and the debenture trustee
with the written consent of the holders of at least a majority in
aggregate principal amount of the outstanding debt securities of
each series that is affected. However, we and the debenture
trustee may only make the following changes with the consent of
each holder of any outstanding debt securities affected:
|
● |
extending
the fixed maturity of the series of debt securities; |
|
● |
reducing
the principal amount, reducing the rate of or extending the time of
payment of interest, or reducing any premium payable upon the
redemption of any debt securities; or |
|
● |
reducing
the percentage of debt securities, the holders of which are
required to consent to any amendment, supplement, modification or
waiver. |
Discharge
Each
indenture will provide that we can elect to be discharged from our
obligations with respect to one or more series of debt securities,
except for obligations to:
|
● |
register
the transfer or exchange of debt securities of the
series; |
|
● |
replace
stolen, lost or mutilated debt securities of the
series; |
|
● |
maintain
paying agencies; |
|
● |
hold
monies for payment in trust; |
|
● |
recover
excess money held by the debenture trustee; |
|
● |
compensate
and indemnify the debenture trustee; and |
|
● |
appoint
any successor trustee. |
In
order to exercise our rights to be discharged, we must deposit with
the debenture trustee money or government obligations sufficient to
pay all the principal of, any premium, if any, and interest on, the
debt securities of the series on the dates payments are
due.
Form,
Exchange and Transfer
We
will issue the debt securities of each series only in fully
registered form without coupons and, unless we otherwise specify in
the applicable prospectus supplement, in denominations of $1,000
and any integral multiple thereof. The indenture will provide
that we may issue debt securities of a series in temporary or
permanent global form and as book-entry securities that will be
deposited with, or on behalf of, The Depository Trust Company, New
York, New York, known as DTC, or another depositary named by
us and identified in a prospectus supplement with respect to that
series. See “Legal Ownership of Securities” for a further
description of the terms relating to any book-entry
securities.
At
the option of the holder, subject to the terms of the indentures
and the limitations applicable to global securities described in
the applicable prospectus supplement, the holder of the debt
securities of any series can exchange the debt securities for other
debt securities of the same series, in any authorized denomination
and of like tenor and aggregate principal amount.
Subject
to the terms of the indentures and the limitations applicable to
global securities set forth in the applicable prospectus
supplement, holders of the debt securities may present the debt
securities for exchange or for registration of transfer, duly
endorsed or with the form of transfer endorsed thereon duly
executed if so required by us or the security registrar, at the
office of the security registrar or at the office of any transfer
agent designated by us for this purpose. Unless otherwise
provided in the debt securities that the holder presents for
transfer or exchange, we will make no service charge for any
registration of transfer or exchange, but we may require payment of
any taxes or other governmental charges.
We
will name in the applicable prospectus supplement the security
registrar, and any transfer agent in addition to the security
registrar, that we initially designate for any debt
securities. We may at any time designate additional transfer
agents or rescind the designation of any transfer agent or approve
a change in the office through which any transfer agent acts,
except that we will be required to maintain a transfer agent in
each place of payment for the debt securities of each
series.
If we
elect to redeem the debt securities of any series, we will not be
required to:
|
● |
issue,
register the transfer of, or exchange any debt securities of any
series being redeemed in part during a period beginning at the
opening of business 15 days before the day of mailing of a notice
of redemption of any debt securities that may be selected for
redemption and ending at the close of business on the day of the
mailing; or |
|
● |
register
the transfer of or exchange any debt securities so selected for
redemption, in whole or in part, except the unredeemed portion of
any debt securities we are redeeming in part. |
Information
Concerning the Debenture Trustee
The
debenture trustee, other than during the occurrence and continuance
of an event of default under an indenture, will undertake to
perform only those duties as are specifically set forth in the
applicable indenture. Upon an event of default under an
indenture, the debenture trustee must use the same degree of care
as a prudent person would exercise or use in the conduct of his or
her own affairs. Subject to this provision, the debenture
trustee is under no obligation to exercise any of the powers given
it by the indentures at the request of any holder of debt
securities unless it is offered reasonable security and indemnity
against the costs, expenses and liabilities that it might
incur.
Payment
and Paying Agents
Unless
we otherwise indicate in the applicable prospectus supplement, we
will make payment of the interest on any debt securities on any
interest payment date to the person in whose name the debt
securities, or one or more predecessor securities, are registered
at the close of business on the regular record date for the
interest.
We
will pay principal of and any premium and interest on the debt
securities of a particular series at the office of the paying
agents designated by us, except that, unless we otherwise indicate
in the applicable prospectus supplement, we may make interest
payments by check which we will mail to the holder or by wire
transfer to certain holders. Unless we otherwise indicate in
a prospectus supplement, we will designate the corporate office of
the debenture trustee in the City of Dallas, Texas as our sole
paying agent for payments with respect to debt securities of each
series. We will name in the applicable prospectus supplement
any other paying agents that we initially designate for the debt
securities of a particular series. We will maintain a paying
agent in each place of payment for the debt securities of a
particular series.
All
money we pay to a paying agent or the debenture trustee for the
payment of the principal of or any premium or interest on any debt
securities which remains unclaimed at the end of two years after
such principal, premium or interest has become due and payable will
be repaid to us, and the holder of the debt security thereafter may
look only to us for payment thereof.
Subordination
of Subordinated Debt Securities
The
subordinated debt securities will be subordinate and junior in
priority of payment to certain of our other indebtedness to the
extent described in a prospectus supplement. The indentures
will not limit the amount of indebtedness which we may incur,
including senior indebtedness or subordinated indebtedness, and
will not limit us from issuing any other debt, including secured
debt or unsecured debt.
DESCRIPTION OF
WARRANTS
The
following description, together with the additional information we
may include in any applicable prospectus supplements, summarizes
the material terms and provisions of the warrants that we may offer
under this prospectus. While the terms we have summarized below
will apply generally to any warrants that we may offer under this
prospectus, we will describe the particular terms of any series of
warrants in more detail in the applicable prospectus supplement.
The terms of any warrants offered under a prospectus
supplement may differ from the terms described below. However, no
prospectus supplement will fundamentally change the terms that are
set forth in this prospectus or offer a security that is not
registered and described in this prospectus at the time of its
effectiveness.
We
will file as exhibits to the registration statement of which this
prospectus is a part, or will incorporate by reference from a
Current Report on Form 8-K that we file with the SEC, the form of
warrant agreement, including a form of warrant certificate, that
describes the terms of the particular series of warrants we are
offering before the issuance of the related series of warrants. The
following summaries of material provisions of the warrants and the
warrant agreements are subject to, and qualified in their entirety
by reference to, all the provisions of the warrant agreement and
warrant certificate applicable to a particular series of warrants.
We urge you to read the applicable prospectus supplements related
to the particular series of warrants that we sell under this
prospectus, as well as the complete warrant agreements and warrant
certificates that contain the terms of the warrants.
General
We
will describe in the applicable prospectus supplement the terms
relating to a series of warrants, including:
|
● |
the
offering price and aggregate number of warrants
offered; |
|
● |
the
currency for which the warrants may be purchased; |
|
● |
if
applicable, the designation and terms of the securities with which
the warrants are issued and the number of warrants issued with each
such security or each principal amount of such
security; |
|
● |
if
applicable, the date on and after which the warrants and the
related securities will be separately transferable; |
|
● |
in
the case of warrants to purchase debt securities, the principal
amount of debt securities purchasable upon exercise of one warrant
and the price at which, and currency in which, this principal
amount of debt securities may be purchased upon such
exercise; |
|
● |
in
the case of warrants to purchase common stock, the number of shares
of common stock may be, purchasable upon the exercise of one
warrant and the price at which these shares may be purchased upon
such exercise; |
|
● |
the
effect of any merger, consolidation, sale or other disposition of
our business on the warrant agreements and the
warrants; |
|
● |
the
terms of any rights to redeem or call the warrants; |
|
● |
any
provisions for changes to or adjustments in the exercise price or
number of securities issuable upon exercise of the
warrants; |
|
● |
the
dates on which the right to exercise the warrants will commence and
expire; |
|
● |
the
manner in which the warrant agreements and warrants may be
modified; |
|
● |
federal
income tax consequences of holding or exercising the
warrants; |
|
● |
the
terms of the securities issuable upon exercise of the warrants;
and |
|
● |
any
other specific terms, preferences, rights or limitations of or
restrictions on the warrants. |
Before
exercising their warrants, holders of warrants will not have any of
the rights of holders of the securities purchasable upon such
exercise, including:
|
● |
in
the case of warrants to purchase debt securities, the right to
receive payments of principal of, or premium, if any, or interest
on, the debt securities purchasable upon exercise or to enforce
covenants in the applicable indenture; and |
|
● |
in
the case of warrants to purchase common stock, the rights of common
stock holders such as, but not limited to, the right to participate
in voting on shareholder and/or company matters. |
Exercise
of Warrants
Each
warrant will entitle the holder to purchase the securities that we
specify in the applicable prospectus supplement at the exercise
price that we describe in the applicable prospectus supplement.
Unless we otherwise specify in the applicable prospectus
supplement, holders of the warrants may exercise the warrants at
any time up to the specified time on the expiration date that we
set forth in the applicable prospectus supplement. After the close
of business on the expiration date, unexercised warrants will
become void.
Holders
of the warrants may exercise the warrants by delivering the warrant
certificate representing the warrants to be exercised together with
specified information, and paying the required amount to the
warrant agent in immediately available funds, as provided in the
applicable prospectus supplement. We will set forth on the reverse
side of the warrant certificate and in the applicable prospectus
supplement the information that the holder of the warrant will be
required to deliver to the warrant agent.
Upon
receipt of the required payment and the warrant certificate
properly completed and duly executed at the corporate trust office
of the warrant agent or any other office indicated in the
applicable prospectus supplement, we will issue and deliver the
securities purchasable upon such exercise. If fewer than all of the
warrants represented by the warrant certificate are exercised, then
we will issue a new warrant certificate for the remaining amount of
warrants. If we so indicate in the applicable prospectus
supplement, holders of the warrants may surrender securities as all
or part of the exercise price for warrants.
Enforceability
of Rights by Holders of Warrants
Each
warrant agent will act solely as our agent under the applicable
warrant agreement and will not assume any obligation or
relationship of agency or trust with any holder of any
warrant. A single bank or trust company may act as warrant
agent for more than one issue of warrants. A warrant agent
will have no duty or responsibility in case of any default by us
under the applicable warrant agreement or warrant, including any
duty or responsibility to initiate any proceedings at law or
otherwise, or to make any demand upon us. Any holder of a
warrant may, without the consent of the related warrant agent or
the holder of any other warrant, enforce by appropriate legal
action its right to exercise, and receive the securities
purchasable upon exercise of, its warrants.
DESCRIPTION OF
UNITS
The
following description, together with the additional information we
may include in any applicable prospectus supplements, summarizes
the material terms and provisions of the units that we may offer
under this prospectus. While the terms we have summarized below
will apply generally to any units that we may offer under this
prospectus, we will describe the particular terms of any series of
units in more detail in the applicable prospectus supplement. The
terms of any units offered under a prospectus supplement may differ
from the terms described below. However, no prospectus supplement
will fundamentally change the terms that are set forth in this
prospectus or offer a security that is not registered and described
in this prospectus at the time of its effectiveness.
We
will file as exhibits to the registration statement of which this
prospectus is a part, or will incorporate by reference from a
Current Report on Form 8-K that we file with the SEC, the form of
unit agreement that describes the terms of the series of units we
are offering, and any supplemental agreements, before the issuance
of the related series of units. The following summaries of material
terms and provisions of the units are subject to, and qualified in
their entirety by reference to, all the provisions of the unit
agreement and any supplemental agreements applicable to a
particular series of units. We urge you to read the applicable
prospectus supplements related to the particular series of units
that we sell under this prospectus, as well as the complete unit
agreement and any supplemental agreements that contain the terms of
the units.
General
We
may issue units comprised of one or more debt securities, shares of
common stock and warrants in any combination. Each unit will be
issued so that the holder of the unit is also the holder of each
security included in the unit. Thus, the holder of a unit will have
the rights and obligations of a holder of each included security.
The unit agreement under which a unit is issued may provide that
the securities included in the unit may not be held or transferred
separately, at any time or at any time before a specified
date.
We
will describe in the applicable prospectus supplement the terms of
the series of units, including:
|
● |
the designation and terms of the
units and of the securities comprising the units, including whether
and under what circumstances those securities may be held or
transferred separately; |
|
● |
any provisions of the governing
unit agreement that differ from those described below; and |
|
● |
any provisions for the issuance,
payment, settlement, transfer or exchange of the units or of the
securities comprising the units. |
The
provisions described in this section, as well as those described
under “Description of Capital Stock,” “Description of Debt
Securities” and “Description of Warrants” will apply to each unit
and to any common stock, debt security or warrant included in each
unit, respectively.
Issuance
in Series
We
may issue units in such amounts and in numerous distinct series as
we determine.
Enforceability
of Rights by Holders of Units
Each
unit agent will act solely as our agent under the applicable unit
agreement and will not assume any obligation or relationship of
agency or trust with any holder of any unit. A single bank or trust
company may act as unit agent for more than one series of units. A
unit agent will have no duty or responsibility in case of any
default by us under the applicable unit agreement or unit,
including any duty or responsibility to initiate any proceedings at
law or otherwise, or to make any demand upon us. Any holder of a
unit may, without the consent of the related unit agent or the
holder of any other unit, enforce by appropriate legal action its
rights as holder under any security included in the
unit.
Title
We,
the unit agents and any of their agents may treat the registered
holder of any unit certificate as an absolute owner of the units
evidenced by that certificate for any purpose and as the person
entitled to exercise the rights attaching to the units so
requested, despite any notice to the contrary. See “Legal Ownership
of Securities.”
LEGAL OWNERSHIP OF
SECURITIES
We
can issue securities in registered form or in the form of one or
more global securities. We describe global securities in
greater detail below. We refer to those persons who have
securities registered in their own names on the books that we or
any applicable trustee or depositary or warrant agent maintain for
this purpose as the “holders” of those securities. These
persons are the legal holders of the securities. We refer to
those persons who, indirectly through others, own beneficial
interests in securities that are not registered in their own names,
as “indirect holders” of those securities. As we discuss
below, indirect holders are not legal holders, and investors in
securities issued in book-entry form or in street name will be
indirect holders.
Book-Entry
Holders
We
may issue securities in book-entry form only, as we will specify in
the applicable prospectus supplement. This means securities
may be represented by one or more global securities registered in
the name of a financial institution that holds them as depositary
on behalf of other financial institutions that participate in the
depositary’s book-entry system. These participating
institutions, which are referred to as participants, in turn,
hold beneficial interests in the securities on behalf of themselves
or their customers.
Only
the person in whose name a security is registered is recognized as
the holder of that security. Global securities will be
registered in the name of the depositary. Consequently, for
global securities, we will recognize only the depositary as the
holder of the securities, and we will make all payments on the
securities to the depositary. The depositary passes along the
payments it receives to its participants, which in turn pass the
payments along to their customers who are the beneficial
owners. The depositary and its participants do so under
agreements they have made with one another or with their customers;
they are not obligated to do so under the terms of the
securities.
As a
result, investors in a global security will not own securities
directly. Instead, they will own beneficial interests in a
global security, through a bank, broker or other financial
institution that participates in the depositary’s book-entry system
or holds an interest through a participant. As long as the
securities are issued in global form, investors will be indirect
holders, and not holders, of the securities.
Street
Name Holders
We
may terminate global securities or issue securities that are not
issued in global form. In these cases, investors may choose
to hold their securities in their own names or in “street name.”
Securities held by an investor in street name would be registered
in the name of a bank, broker or other financial institution that
the investor chooses, and the investor would hold only a beneficial
interest in those securities through an account he or she maintains
at that institution.
For
securities held in street name, we or any applicable trustee or
depositary will recognize only the intermediary banks, brokers and
other financial institutions in whose names the securities are
registered as the holders of those securities, and we or any such
trustee or depositary will make all payments on those securities to
them. These institutions pass along the payments they receive
to their customers who are the beneficial owners, but only because
they agree to do so in their customer agreements or because they
are legally required to do so. Investors who hold securities
in street name will be indirect holders, not holders, of those
securities.
Legal
Holders
Our
obligations, as well as the obligations of any applicable trustee
or third party employed by us or a trustee, run only to the legal
holders of the securities. We do not have obligations to
investors who hold beneficial interests in global securities, in
street name or by any other indirect means. This will be the
case whether an investor chooses to be an indirect holder of a
security or has no choice because we are issuing the securities
only in global form.
For
example, once we make a payment or give a notice to the holder, we
have no further responsibility for the payment or notice even if
that holder is required, under agreements with its participants or
customers or by law, to pass it along to the indirect holders but
does not do so. Similarly, we may want to obtain the approval
of the holders to amend an indenture, to relieve us of the
consequences of a default or of our obligation to comply with a
particular provision of an indenture, or for other purposes.
In such an event, we would seek approval only from the holders, and
not the indirect holders, of the securities. Whether and how
the holders contact the indirect holders is up to the
holders.
Special
Considerations for Indirect Holders
If
you hold securities through a bank, broker or other financial
institution, either in book-entry form because the securities are
represented by one or more global securities or in street name, you
should check with your own institution to find out:
|
● |
how
it handles securities payments and notices; |
|
● |
whether
it imposes fees or charges; |
|
● |
how
it would handle a request for the holders’ consent, if ever
required; |
|
● |
whether and how you can instruct it
to send you securities registered in your own name so you can be a
holder, if that is permitted in the future; |
|
● |
how it would exercise rights under
the securities if there were a default or other event triggering
the need for holders to act to protect their interests; and |
|
● |
if the securities are in book-entry
form, how the depositary’s rules and procedures will affect these
matters. |
Global
Securities
A
global security is a security that represents one or any other
number of individual securities held by a depositary.
Generally, all securities represented by the same global securities
will have the same terms.
Each
security issued in book-entry form will be represented by a global
security that we issue to, deposit with and register in the name of
a financial institution or its nominee that we select. The
financial institution that we select for this purpose is called the
depositary. Unless we specify otherwise in the applicable
prospectus supplement, The Depository Trust Company, New York, New
York, known as DTC, will be the depositary for all securities
issued in book-entry form.
A
global security may not be transferred to or registered in the name
of anyone other than the depositary, its nominee or a successor
depositary, unless special termination situations arise. We
describe those situations below under “Special Situations When a
Global Security Will Be Terminated.” As a result of these
arrangements, the depositary, or its nominee, will be the sole
registered owner and holder of all securities represented by a
global security, and investors will be permitted to own only
beneficial interests in a global security. Beneficial
interests must be held by means of an account with a broker, bank
or other financial institution that in turn has an account with the
depositary or with another institution that does. Thus, an
investor whose security is represented by a global security will
not be a holder of the security, but only an indirect holder of a
beneficial interest in the global security.
If
the prospectus supplement for a particular security indicates that
the security will be issued as a global security, then the security
will be represented by a global security at all times unless and
until the global security is terminated. If termination
occurs, we may issue the securities through another book-entry
clearing system or decide that the securities may no longer be held
through any book-entry clearing system.
Special
Considerations For Global Securities
As an
indirect holder, an investor’s rights relating to a global security
will be governed by the account rules of the investor’s financial
institution and of the depositary, as well as general laws relating
to securities transfers. We do not recognize an indirect
holder as a holder of securities and instead deal only with
the depositary that holds the global security.
If
securities are issued only as global securities, an investor should
be aware of the following:
|
● |
an investor cannot cause the
securities to be registered in his or her name, and cannot obtain
non-global certificates for his or her interest in the securities,
except in the special situations we describe below; |
|
● |
an investor will be an indirect
holder and must look to his or her own bank or broker for payments
on the securities and protection of his or her legal rights
relating to the securities, as we describe above; |
|
● |
an investor may not be able to sell
interests in the securities to some insurance companies and to
other institutions that are required by law to own their securities
in non-book-entry form; |
|
● |
an investor may not be able to
pledge his or her interest in the global security in circumstances
where certificates representing the securities must be delivered to
the lender or other beneficiary of the pledge in order for the
pledge to be effective; |
|
● |
the depositary’s policies, which
may change from time to time, will govern payments, transfers,
exchanges and other matters relating to an investor’s interest in
the global security. We and any applicable trustee have no
responsibility for any aspect of the depositary’s actions or for
its records of ownership interests in the global security. We
and the trustee also do not supervise the depositary in any
way; |
|
● |
the depositary may, and we
understand that DTC will, require that those who purchase and sell
interests in the global security within its book-entry system use
immediately available funds, and your broker or bank may require
you to do so as well; and |
|
● |
financial institutions that
participate in the depositary’s book-entry system, and through
which an investor holds its interest in the global security, may
also have their own policies affecting payments, notices and other
matters relating to the securities. There may be more than
one financial intermediary in the chain of ownership for an
investor. We do not monitor and are not responsible for the
actions of any of those intermediaries. |
Special
Situations When A Global Security Will Be Terminated
In a
few special situations described below, a global security will
terminate and interests in it will be exchanged for physical
certificates representing those interests. After that
exchange, the choice of whether to hold securities directly or in
street name will be up to the investor. Investors must
consult their own banks or brokers to find out how to have their
interests in securities transferred to their own names, so that
they will be direct holders. We have described the rights of
holders and street name investors above.
A
global security will terminate when the following special
situations occur:
|
● |
if the depositary notifies us that
it is unwilling, unable or no longer qualified to continue as
depositary for that global security and we do not appoint another
institution to act as depositary within 90 days; |
|
● |
if we notify any applicable trustee
that we wish to terminate that global security; or |
|
● |
if an event of default has occurred
with regard to securities represented by that global security and
has not been cured or waived. |
The
prospectus supplement may also list additional situations for
terminating a global security that would apply only to the
particular series of securities covered by the prospectus
supplement. When a global security terminates, the
depositary, and not we or any applicable trustee, is responsible
for deciding the names of the institutions that will be the initial
direct holders.
PLAN OF
DISTRIBUTION
We
may sell the securities to or through underwriters or dealers,
through agents, or directly to one or more purchasers. A
prospectus supplement or supplements will describe the terms of the
offering of the securities, including, to the extent
applicable:
|
● |
the
name or names of any underwriters or agents; |
|
● |
the
purchase price of the securities and the proceeds we will receive
from the sale; |
|
● |
any
over-allotment options under which underwriters may purchase
additional securities from us; |
|
● |
any
agency fees or underwriting discounts and other items constituting
agents’ or underwriters’ compensation; |
|
● |
any
public offering price; |
|
● |
any
discounts or concessions allowed or re-allowed or paid to dealers;
and |
|
● |
any
securities exchange or market on which the securities may be
listed. |
We
may distribute the securities from time to time in one or more
transactions at:
|
● |
fixed
price or prices, which may be changed from time to
time; |
|
● |
market prices prevailing at the time of sale; |
|
● |
prices related to such prevailing market prices; or |
Underwriters
If we
use underwriters for a sale of securities, the underwriters will
acquire the securities for their own account. The underwriters may
resell the securities in one or more transactions, including
negotiated transactions, at a fixed public offering price or at
varying prices determined at the time of sale. The obligations of
the underwriters to purchase the securities will be subject to the
conditions set forth in the applicable underwriting agreement. We
may offer the securities to the public through underwriting
syndicates represented by managing underwriters or by underwriters
without a syndicate. Subject to certain conditions, the
underwriters will be obligated to purchase all the securities of
the series offered if they purchase any of the securities of that
series. We may change from time to time any public offering price
and any discounts or concessions the underwriters allow or pay to
dealers. We may use underwriters with whom we have a material
relationship. We will describe the nature of any such relationship
in any applicable prospectus supplement naming any such
underwriter. Only underwriters we name in the prospectus supplement
are underwriters of the securities offered by the prospectus
supplement.
We
may provide agents and underwriters with indemnification against
civil liabilities related to offerings under this prospectus,
including liabilities under the Securities Act, or contribution
with respect to payments that the agents or underwriters may make
with respect to these liabilities.
Agents
We
may designate agents who agree to use their reasonable efforts to
solicit purchases of our securities for the period of their
appointment or to sell our securities on a continuing basis. We
will name any agent involved in the offering and sale of securities
and we will describe any commissions we will pay the agent in the
applicable prospectus supplement. Unless the prospectus
supplement states otherwise, our agent will act on a best-efforts
basis for the period of its appointment.
We
may authorize agents or underwriters to solicit offers by certain
types of institutional investors to purchase securities from us at
the public offering price set forth in the prospectus supplement
pursuant to delayed delivery contracts providing for payment and
delivery on a specified date in the future. We will describe
the conditions to these contracts and the commissions we must pay
for solicitation of these contracts in the prospectus
supplement.
We
may provide agents and underwriters with indemnification against
civil liabilities related to this offering, including liabilities
under the Securities Act, or contribution with respect to payments
that the agents or underwriters may make with respect to these
liabilities. Agents and underwriters may engage in
transactions with, or perform services for, us in the ordinary
course of business.
Direct
Sales
We
may also sell securities directly to one or more purchasers without
using underwriters or agents. We intend to offer securities direct
to investors through our Dividend Reinvestment and Common Stock
Purchase Plan.
Trading
Markets and Listing of Securities
Unless
otherwise specified in the applicable prospectus supplement, each
class or series of securities will be a new issue with no
established trading market, other than our common stock, which is
currently listed on the OTCQX. We may elect to list our common
stock or any other class or series of securities on any exchange or
market, but we are not obligated to do so. It is possible that one
or more underwriters may make a market in a class or series of
securities, but the underwriters will not be obligated to do
so and may discontinue any market making at any time without
notice. We cannot give any assurance as to the liquidity of the
trading market for any of the securities.
Stabilization
Activities
Any
underwriter may engage in overallotment, stabilizing transactions,
short covering transactions and penalty bids in accordance with
Regulation M under the Exchange Act. Overallotment involves
sales in excess of the offering size, which create a short
position. Stabilizing transactions permit bids to purchase the
underlying security so long as the stabilizing bids do not exceed a
specified maximum. Short covering transactions involve purchases of
the securities in the open market after the distribution is
completed to cover short positions. Penalty bids permit the
underwriters to reclaim a selling concession from a dealer when the
securities originally sold by the dealer are purchased in a
covering transaction to cover short positions. Those activities may
cause the price of the securities to be higher than it would
otherwise be. If commenced, the underwriters may discontinue any of
these activities at any time.
LEGAL
MATTERS
The
validity of the securities being offered by this prospectus will be
passed upon for us by Aboudi Legal Group PLLC. If the validity of
any securities is also passed upon by counsel for any underwriters,
dealers or agents, that counsel will be named in the prospectus
supplement relating to that specific offering.
EXPERTS
The
audited financial statements of Zion Oil & Gas, Inc. as of
December 31, 2020 and December 31, 2019 and management’s assessment
of the effectiveness of internal control over financial reporting
as of December 31, 2020 and December 31, 2019 have been
incorporated by reference herein in reliance upon the reports of
RBSM LLP, an independent registered public accounting
firm.
WHERE YOU CAN FIND MORE
INFORMATION
We
are subject to the reporting requirements of the Exchange Act and
file annual, quarterly and current reports, proxy statements and
other information with the SEC. You may read and copy these
reports, proxy statements and other information at the SEC’s Public
Reference Room at 100 F Street, N.E., Washington, DC 20549. You can
request copies of these documents by writing to the SEC and paying
a fee for the copying cost. Please call the SEC at 1-800-SEC-0330
for further information on the Public Reference Room. The SEC also
maintains an Internet site that contains reports, proxy statements
and other information about issuers, like us, who file
electronically with the SEC. The address of the SEC’s web site is
http://www.sec.gov. Our
common stock is listed for trading on the OTCQX under the symbol
“ZNOG” and our warrant is listed for trading on the OTCQX under the
symbol “ZNOGW”
We
have filed a registration statement converting a Form S-1 into a
Form S-3 with the SEC to register the securities that may be
offered pursuant to this prospectus. This prospectus is part of
that registration statement and, as permitted by the SEC’s rules,
does not contain all of the information included in the
registration statement. For further information about us, this
offering and our common stock, you may refer to the registration
statement and its exhibits and schedules as well as the documents
described herein or incorporated herein by reference. You can
review and copy these documents, without charge, at the public
reference facilities maintained by the SEC or on the SEC’s website
as described above or you may obtain a copy from the SEC upon
payment of the fees prescribed by the SEC.
INCORPORATION OF CERTAIN
INFORMATION BY REFERENCE
As a
Smaller Reporting Company, the SEC allows us to “incorporate by
reference” the information we file with them, which means that we
can disclose important information to you by referring you to those
documents. The information we incorporate by reference is
considered to be an important part of this prospectus, and
information that we file with the SEC at a later date will
automatically add to, update or supersede this
information.
We
incorporate by reference into this prospectus the documents listed
below:
|
● |
our annual report on
Form 10-K for the year ended December 31, 2020 filed on March
24, 2021; |
|
● |
the
description of our common stock in our registration statement on
Form 8-A filed with the SEC on December 29, 2006, including any
amendments or reports filed for the purpose of updating such
description; and |
|
● |
all
future filings that we make with the SEC under Section 13(a),
13(c), 14, or 15(d) of the Exchange Act after the date of filing of
the registration statement on Form S-1 of which this prospectus is
a part and prior to the termination or completion of any offering
of securities under this prospectus and all applicable prospectus
supplements (except, in each case, for information contained in any
such filing that is furnished and not “filed” under the Exchange
Act), which filings will be deemed to be incorporated by reference
in this prospectus, as supplemented by the applicable prospectus
supplement, and to be a part hereof from the respective dates of
such filings. |
We
will provide without charge to each person, including any
beneficial owner, to whom this prospectus is delivered, upon
written or oral request of such person, a copy of any or all of the
information that is incorporated by reference in this prospectus.
Requests for such documents should be directed to: Shareholder
Relations, Zion Oil & Gas, Inc., 12655 North Central
Expressway, Suite 1000, Dallas, TX 75243.
This
prospectus is part of a registration statement on Form S-3 that we
filed with the SEC. That registration statement contains more
information than this prospectus regarding us and our common stock,
including certain exhibits and schedules. You can obtain a copy of
the registration statement from the SEC at the address listed above
or from the SEC’s Internet website.
You
should rely only on the information provided in and incorporated by
reference into this prospectus or any prospectus supplement. We
have not authorized anyone else to provide you with different
information. You should not assume that the information in this
prospectus or any prospectus supplement is accurate as of any date
other than the date on the front cover of these
documents.
Zion Oil and Gas (QX) (USOTC:ZNOG)
Historical Stock Chart
From Apr 2022 to May 2022
Zion Oil and Gas (QX) (USOTC:ZNOG)
Historical Stock Chart
From May 2021 to May 2022